BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1372453 Oc1c(F)cc(cc1C=O)C(=O)Nc1nnc(s1)N1CCCCC1 InChI=1S/C15H15FN4O3S/c16-11-7-9(6-10(8-21)12(11)22)13(23)17-14-18-19-15(24-14)20-4-2-1-3-5-20/h6-8,22H,1-5H2,(H,17,18,23) JPGQXFTVOJEORG-UHFFFAOYSA-N 649694 3-fluoro-5-formyl-4-hydroxy- N-(5-(piperidin-1-yl)-1,3,4- thiadiazol-2-yl)benzamide::US20240043395, Compound 1 Toll-like receptor 2 Homo sapiens 45800 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649694 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649694&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230067 494494538 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372454 Oc1c(F)cc(cc1C=O)C(=O)Nc1nnc(s1)N1CCCCC1 InChI=1S/C15H15FN4O3S/c16-11-7-9(6-10(8-21)12(11)22)13(23)17-14-18-19-15(24-14)20-4-2-1-3-5-20/h6-8,22H,1-5H2,(H,17,18,23) JPGQXFTVOJEORG-UHFFFAOYSA-N 649694 3-fluoro-5-formyl-4-hydroxy- N-(5-(piperidin-1-yl)-1,3,4- thiadiazol-2-yl)benzamide::US20240043395, Compound 1 Toll-like receptor 6 Homo sapiens 21800 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649694 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649694&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230067 494494538 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372455 Oc1c(F)cc(cc1C=O)C(=O)Nc1nnc(s1)-c1ccccc1 InChI=1S/C16H10FN3O3S/c17-12-7-10(6-11(8-21)13(12)22)14(23)18-16-20-19-15(24-16)9-4-2-1-3-5-9/h1-8,22H,(H,18,20,23) BAJDXSYSVGZFAW-UHFFFAOYSA-N 649695 3-fluoro-5-formyl-4-hydroxy- N-(5-phenyl-1,3,4-thiadiazol- 2-yl)benzamide::US20240043395, Compound 2 Toll-like receptor 2 Homo sapiens 6700 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649695 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649695&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230303 494494539 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372456 Oc1c(F)cc(cc1C=O)C(=O)Nc1nnc(s1)-c1ccccc1 InChI=1S/C16H10FN3O3S/c17-12-7-10(6-11(8-21)13(12)22)14(23)18-16-20-19-15(24-16)9-4-2-1-3-5-9/h1-8,22H,(H,18,20,23) BAJDXSYSVGZFAW-UHFFFAOYSA-N 649695 3-fluoro-5-formyl-4-hydroxy- N-(5-phenyl-1,3,4-thiadiazol- 2-yl)benzamide::US20240043395, Compound 2 Toll-like receptor 6 Homo sapiens 2200 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649695 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649695&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230303 494494539 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372457 Oc1c(F)cc(cc1C=O)C(=O)Nc1nnc(s1)-c1ccccc1 InChI=1S/C16H10FN3O3S/c17-12-7-10(6-11(8-21)13(12)22)14(23)18-16-20-19-15(24-16)9-4-2-1-3-5-9/h1-8,22H,(H,18,20,23) BAJDXSYSVGZFAW-UHFFFAOYSA-N 649695 3-fluoro-5-formyl-4-hydroxy- N-(5-phenyl-1,3,4-thiadiazol- 2-yl)benzamide::US20240043395, Compound 2 Toll-like receptor 9 Homo sapiens 500 US Patent 10.7270/Q2F47T9N aid1963364 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649695 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9962&target=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649695&enzyme=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search 163230303 494494539 1 MGFCRSALHPLSLLVQAIMLAMTLALGTLPAFLPCELQPHGLVNCNWLFLKSVPHFSMAAPRGNVTSLSLSSNRIHHLHDSDFAHLPSLRHLNLKWNCPPVGLSPMHFPCHMTIEPSTFLAVPTLEELNLSYNNIMTVPALPKSLISLSLSHTNILMLDSASLAGLHALRFLFMDGNCYYKNPCRQALEVAPGALLGLGNLTHLSLKYNNLTVVPRNLPSSLEYLLLSYNRIVKLAPEDLANLTALRVLDVGGNCRRCDHAPNPCMECPRHFPQLHPDTFSHLSRLEGLVLKDSSLSWLNASWFRGLGNLRVLDLSENFLYKCITKTKAFQGLTQLRKLNLSFNYQKRVSFAHLSLAPSFGSLVALKELDMHGIFFRSLDETTLRPLARLPMLQTLRLQMNFINQAQLGIFRAFPGLRYVDLSDNRISGASELTATMGEADGGEKVWLQPGDLAPAPVDTPSSEDFRPNCSTLNFTLDLSRNNLVTVQPEMFAQLSHLQCLRLSHNCISQAVNGSQFLPLTGLQVLDLSHNKLDLYHEHSFTELPRLEALDLSYNSQPFGMQGVGHNFSFVAHLRTLRHLSLAHNNIHSQVSQQLCSTSLRALDFSGNALGHMWAEGDLYLHFFQGLSGLIWLDLSQNRLHTLLPQTLRNLPKSLQVLRLRDNYLAFFKWWSLHFLPKLEVLDLAGNQLKALTNGSLPAGTRLRRLDVSCNSISFVAPGFFSKAKELRELNLSANALKTVDHSWFGPLASALQILDVSANPLHCACGAAFMDFLLEVQAAVPGLPSRVKCGSPGQLQGLSIFAQDLRLCLDEALSWDCFALSLLAVALGLGVPMLHHLCGWDLWYCFHLCLAWLPWRGRQSGRDEDALPYDAFVVFDKTQSAVADWVYNELRGQLEECRGRWALRLCLEERDWLPGKTLFENLWASVYGSRKTLFVLAHTDRVSGLLRASFLLAQQRLLEDRKDVVVLVILSPDGRRSRYVRLRQRLCRQSVLLWPHQPSGQRSFWAQLGMALTRDNHHFYNRNFCQGPTAE 8AR3 Toll-like receptor 9 TLR9_HUMAN Q9NR96 B3Y661 D1CS56 Q6UVZ2 Q9HD68 Q9HD69 Q9HD70 Q9NYC2 Q9NYC3 1372458 Oc1c(F)cc(cc1C=O)C(=O)Nc1ncc(s1)N1CCCCC1 InChI=1S/C16H16FN3O3S/c17-12-7-10(6-11(9-21)14(12)22)15(23)19-16-18-8-13(24-16)20-4-2-1-3-5-20/h6-9,22H,1-5H2,(H,18,19,23) KXWAYNAASXUVTL-UHFFFAOYSA-N 649696 3-fluoro-5-formyl-4-hydroxy- N-(5-(piperidin-1-yl)thiazol-2- yl)benzamide::US20240043395, Compound 3 Toll-like receptor 2 Homo sapiens 2300 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649696 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649696&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163229976 494494540 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372459 Oc1c(F)cc(cc1C=O)C(=O)Nc1ncc(s1)N1CCCCC1 InChI=1S/C16H16FN3O3S/c17-12-7-10(6-11(9-21)14(12)22)15(23)19-16-18-8-13(24-16)20-4-2-1-3-5-20/h6-9,22H,1-5H2,(H,18,19,23) KXWAYNAASXUVTL-UHFFFAOYSA-N 649696 3-fluoro-5-formyl-4-hydroxy- N-(5-(piperidin-1-yl)thiazol-2- yl)benzamide::US20240043395, Compound 3 Toll-like receptor 6 Homo sapiens 1700 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649696 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649696&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163229976 494494540 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372460 Oc1c(F)cc(cc1C=O)C(=O)Nc1ncc(s1)-c1ccccc1 InChI=1S/C17H11FN2O3S/c18-13-7-11(6-12(9-21)15(13)22)16(23)20-17-19-8-14(24-17)10-4-2-1-3-5-10/h1-9,22H,(H,19,20,23) BFDXAFCWAUVMSC-UHFFFAOYSA-N 649697 3-fluoro-5-formyl-4-hydroxy- N-(5-phenylthiazol-2- yl)benzamide::US20240043395, Compound 4 Toll-like receptor 2 Homo sapiens 900 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649697 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649697&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230414 494494541 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372461 Oc1c(F)cc(cc1C=O)C(=O)Nc1ncc(s1)-c1ccccc1 InChI=1S/C17H11FN2O3S/c18-13-7-11(6-12(9-21)15(13)22)16(23)20-17-19-8-14(24-17)10-4-2-1-3-5-10/h1-9,22H,(H,19,20,23) BFDXAFCWAUVMSC-UHFFFAOYSA-N 649697 3-fluoro-5-formyl-4-hydroxy- N-(5-phenylthiazol-2- yl)benzamide::US20240043395, Compound 4 Toll-like receptor 6 Homo sapiens 500 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649697 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649697&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230414 494494541 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372462 Oc1c(F)cc(cc1C=O)C(=O)Nc1ncc(s1)-c1ccccc1 InChI=1S/C17H11FN2O3S/c18-13-7-11(6-12(9-21)15(13)22)16(23)20-17-19-8-14(24-17)10-4-2-1-3-5-10/h1-9,22H,(H,19,20,23) BFDXAFCWAUVMSC-UHFFFAOYSA-N 649697 3-fluoro-5-formyl-4-hydroxy- N-(5-phenylthiazol-2- yl)benzamide::US20240043395, Compound 4 Toll-like receptor 9 Homo sapiens 200 US Patent 10.7270/Q2F47T9N aid1963364 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649697 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9962&target=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649697&enzyme=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search 163230414 494494541 1 MGFCRSALHPLSLLVQAIMLAMTLALGTLPAFLPCELQPHGLVNCNWLFLKSVPHFSMAAPRGNVTSLSLSSNRIHHLHDSDFAHLPSLRHLNLKWNCPPVGLSPMHFPCHMTIEPSTFLAVPTLEELNLSYNNIMTVPALPKSLISLSLSHTNILMLDSASLAGLHALRFLFMDGNCYYKNPCRQALEVAPGALLGLGNLTHLSLKYNNLTVVPRNLPSSLEYLLLSYNRIVKLAPEDLANLTALRVLDVGGNCRRCDHAPNPCMECPRHFPQLHPDTFSHLSRLEGLVLKDSSLSWLNASWFRGLGNLRVLDLSENFLYKCITKTKAFQGLTQLRKLNLSFNYQKRVSFAHLSLAPSFGSLVALKELDMHGIFFRSLDETTLRPLARLPMLQTLRLQMNFINQAQLGIFRAFPGLRYVDLSDNRISGASELTATMGEADGGEKVWLQPGDLAPAPVDTPSSEDFRPNCSTLNFTLDLSRNNLVTVQPEMFAQLSHLQCLRLSHNCISQAVNGSQFLPLTGLQVLDLSHNKLDLYHEHSFTELPRLEALDLSYNSQPFGMQGVGHNFSFVAHLRTLRHLSLAHNNIHSQVSQQLCSTSLRALDFSGNALGHMWAEGDLYLHFFQGLSGLIWLDLSQNRLHTLLPQTLRNLPKSLQVLRLRDNYLAFFKWWSLHFLPKLEVLDLAGNQLKALTNGSLPAGTRLRRLDVSCNSISFVAPGFFSKAKELRELNLSANALKTVDHSWFGPLASALQILDVSANPLHCACGAAFMDFLLEVQAAVPGLPSRVKCGSPGQLQGLSIFAQDLRLCLDEALSWDCFALSLLAVALGLGVPMLHHLCGWDLWYCFHLCLAWLPWRGRQSGRDEDALPYDAFVVFDKTQSAVADWVYNELRGQLEECRGRWALRLCLEERDWLPGKTLFENLWASVYGSRKTLFVLAHTDRVSGLLRASFLLAQQRLLEDRKDVVVLVILSPDGRRSRYVRLRQRLCRQSVLLWPHQPSGQRSFWAQLGMALTRDNHHFYNRNFCQGPTAE 8AR3 Toll-like receptor 9 TLR9_HUMAN Q9NR96 B3Y661 D1CS56 Q6UVZ2 Q9HD68 Q9HD69 Q9HD70 Q9NYC2 Q9NYC3 1372463 Oc1c(F)cc(cc1C=O)C(=O)Nc1ncc(s1)N1CCN(CC1)C1CC1 InChI=1S/C18H19FN4O3S/c19-14-8-11(7-12(10-24)16(14)25)17(26)21-18-20-9-15(27-18)23-5-3-22(4-6-23)13-1-2-13/h7-10,13,25H,1-6H2,(H,20,21,26) KLVMUDMVWJBFRV-UHFFFAOYSA-N 649698 N-(5-(4-cyclopropylpiperazin- 1-yl)thiazol-2-yl)-3-fluoro-5- formyl-4-hydroxybenzamide::US20240043395, Compound 5 Toll-like receptor 2 Homo sapiens 5300 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649698 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649698&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230239 494494542 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372464 Oc1c(F)cc(cc1C=O)C(=O)Nc1ncc(s1)N1CCN(CC1)C1CC1 InChI=1S/C18H19FN4O3S/c19-14-8-11(7-12(10-24)16(14)25)17(26)21-18-20-9-15(27-18)23-5-3-22(4-6-23)13-1-2-13/h7-10,13,25H,1-6H2,(H,20,21,26) KLVMUDMVWJBFRV-UHFFFAOYSA-N 649698 N-(5-(4-cyclopropylpiperazin- 1-yl)thiazol-2-yl)-3-fluoro-5- formyl-4-hydroxybenzamide::US20240043395, Compound 5 Toll-like receptor 6 Homo sapiens 2700 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649698 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649698&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230239 494494542 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372465 Oc1c(F)cc(cc1C=O)C(=O)Nc1nc(cs1)-c1ccccc1 InChI=1S/C17H11FN2O3S/c18-13-7-11(6-12(8-21)15(13)22)16(23)20-17-19-14(9-24-17)10-4-2-1-3-5-10/h1-9,22H,(H,19,20,23) DKYBRBAOKINKHD-UHFFFAOYSA-N 649699 3-fluoro-5-formyl-4-hydroxy- N-(4-phenylthiazol-2- yl)benzamide::US20240043395, Compound 6 Toll-like receptor 2 Homo sapiens 5100 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649699 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649699&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163229933 494494543 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372466 Oc1c(F)cc(cc1C=O)C(=O)Nc1nc(cs1)-c1ccccc1 InChI=1S/C17H11FN2O3S/c18-13-7-11(6-12(8-21)15(13)22)16(23)20-17-19-14(9-24-17)10-4-2-1-3-5-10/h1-9,22H,(H,19,20,23) DKYBRBAOKINKHD-UHFFFAOYSA-N 649699 3-fluoro-5-formyl-4-hydroxy- N-(4-phenylthiazol-2- yl)benzamide::US20240043395, Compound 6 Toll-like receptor 6 Homo sapiens 3300 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649699 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649699&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163229933 494494543 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372467 Oc1c(F)cc(cc1C=O)C(=O)Nc1cnc(s1)N1CCCCC1 InChI=1S/C16H16FN3O3S/c17-12-7-10(6-11(9-21)14(12)22)15(23)19-13-8-18-16(24-13)20-4-2-1-3-5-20/h6-9,22H,1-5H2,(H,19,23) ARILTMQDIQOHJT-UHFFFAOYSA-N 649700 3-fluoro-5-formyl-4-hydroxy- N-(2-(piperidin-1-yl)thiazol-5- yl)benzamide::US20240043395, Compound 7 Toll-like receptor 2 Homo sapiens >100000 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649700 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649700&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230169 494494544 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372468 Oc1c(F)cc(cc1C=O)C(=O)Nc1cnc(s1)N1CCCCC1 InChI=1S/C16H16FN3O3S/c17-12-7-10(6-11(9-21)14(12)22)15(23)19-13-8-18-16(24-13)20-4-2-1-3-5-20/h6-9,22H,1-5H2,(H,19,23) ARILTMQDIQOHJT-UHFFFAOYSA-N 649700 3-fluoro-5-formyl-4-hydroxy- N-(2-(piperidin-1-yl)thiazol-5- yl)benzamide::US20240043395, Compound 7 Toll-like receptor 6 Homo sapiens >100000 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649700 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649700&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230169 494494544 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372469 Oc1c(F)cc(cc1C=O)C(=O)Nc1cnc(s1)N1CCCCC1 InChI=1S/C16H16FN3O3S/c17-12-7-10(6-11(9-21)14(12)22)15(23)19-13-8-18-16(24-13)20-4-2-1-3-5-20/h6-9,22H,1-5H2,(H,19,23) ARILTMQDIQOHJT-UHFFFAOYSA-N 649700 3-fluoro-5-formyl-4-hydroxy- N-(2-(piperidin-1-yl)thiazol-5- yl)benzamide::US20240043395, Compound 7 Toll-like receptor 9 Homo sapiens >33000 US Patent 10.7270/Q2F47T9N aid1963364 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649700 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9962&target=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649700&enzyme=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search 163230169 494494544 1 MGFCRSALHPLSLLVQAIMLAMTLALGTLPAFLPCELQPHGLVNCNWLFLKSVPHFSMAAPRGNVTSLSLSSNRIHHLHDSDFAHLPSLRHLNLKWNCPPVGLSPMHFPCHMTIEPSTFLAVPTLEELNLSYNNIMTVPALPKSLISLSLSHTNILMLDSASLAGLHALRFLFMDGNCYYKNPCRQALEVAPGALLGLGNLTHLSLKYNNLTVVPRNLPSSLEYLLLSYNRIVKLAPEDLANLTALRVLDVGGNCRRCDHAPNPCMECPRHFPQLHPDTFSHLSRLEGLVLKDSSLSWLNASWFRGLGNLRVLDLSENFLYKCITKTKAFQGLTQLRKLNLSFNYQKRVSFAHLSLAPSFGSLVALKELDMHGIFFRSLDETTLRPLARLPMLQTLRLQMNFINQAQLGIFRAFPGLRYVDLSDNRISGASELTATMGEADGGEKVWLQPGDLAPAPVDTPSSEDFRPNCSTLNFTLDLSRNNLVTVQPEMFAQLSHLQCLRLSHNCISQAVNGSQFLPLTGLQVLDLSHNKLDLYHEHSFTELPRLEALDLSYNSQPFGMQGVGHNFSFVAHLRTLRHLSLAHNNIHSQVSQQLCSTSLRALDFSGNALGHMWAEGDLYLHFFQGLSGLIWLDLSQNRLHTLLPQTLRNLPKSLQVLRLRDNYLAFFKWWSLHFLPKLEVLDLAGNQLKALTNGSLPAGTRLRRLDVSCNSISFVAPGFFSKAKELRELNLSANALKTVDHSWFGPLASALQILDVSANPLHCACGAAFMDFLLEVQAAVPGLPSRVKCGSPGQLQGLSIFAQDLRLCLDEALSWDCFALSLLAVALGLGVPMLHHLCGWDLWYCFHLCLAWLPWRGRQSGRDEDALPYDAFVVFDKTQSAVADWVYNELRGQLEECRGRWALRLCLEERDWLPGKTLFENLWASVYGSRKTLFVLAHTDRVSGLLRASFLLAQQRLLEDRKDVVVLVILSPDGRRSRYVRLRQRLCRQSVLLWPHQPSGQRSFWAQLGMALTRDNHHFYNRNFCQGPTAE 8AR3 Toll-like receptor 9 TLR9_HUMAN Q9NR96 B3Y661 D1CS56 Q6UVZ2 Q9HD68 Q9HD69 Q9HD70 Q9NYC2 Q9NYC3 1372470 Oc1c(F)cc(cc1C=O)C(=O)Nc1cnc(s1)N1CCCC1 InChI=1S/C15H14FN3O3S/c16-11-6-9(5-10(8-20)13(11)21)14(22)18-12-7-17-15(23-12)19-3-1-2-4-19/h5-8,21H,1-4H2,(H,18,22) OVDKLCXTBRPXEC-UHFFFAOYSA-N 649701 3-fluoro-5-formyl-4-hydroxy- N-(2-(pyrrolidin-1-yl)thiazol- 5-yl)benzamide::US20240043395, Compound 8 Toll-like receptor 2 Homo sapiens 17700 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649701 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649701&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163229885 494494545 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372471 Oc1c(F)cc(cc1C=O)C(=O)Nc1cnc(s1)N1CCCC1 InChI=1S/C15H14FN3O3S/c16-11-6-9(5-10(8-20)13(11)21)14(22)18-12-7-17-15(23-12)19-3-1-2-4-19/h5-8,21H,1-4H2,(H,18,22) OVDKLCXTBRPXEC-UHFFFAOYSA-N 649701 3-fluoro-5-formyl-4-hydroxy- N-(2-(pyrrolidin-1-yl)thiazol- 5-yl)benzamide::US20240043395, Compound 8 Toll-like receptor 6 Homo sapiens 12900 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649701 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649701&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163229885 494494545 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372472 Oc1c(F)cc(NC(=O)c2csc(n2)N2CCCCC2)cc1C=O InChI=1S/C16H16FN3O3S/c17-12-7-11(6-10(8-21)14(12)22)18-15(23)13-9-24-16(19-13)20-4-2-1-3-5-20/h6-9,22H,1-5H2,(H,18,23) WPCMJOVLZBBYHK-UHFFFAOYSA-N 649702 N-(3-fluoro-5-formyl-4- hydroxyphenyl)-2-(piperidin- 1-yl)thiazole-4-carboxamide::US20240043395, Compound 9 Toll-like receptor 2 Homo sapiens 5200 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649702 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649702&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230376 494494546 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372473 Oc1c(F)cc(NC(=O)c2csc(n2)N2CCCCC2)cc1C=O InChI=1S/C16H16FN3O3S/c17-12-7-11(6-10(8-21)14(12)22)18-15(23)13-9-24-16(19-13)20-4-2-1-3-5-20/h6-9,22H,1-5H2,(H,18,23) WPCMJOVLZBBYHK-UHFFFAOYSA-N 649702 N-(3-fluoro-5-formyl-4- hydroxyphenyl)-2-(piperidin- 1-yl)thiazole-4-carboxamide::US20240043395, Compound 9 Toll-like receptor 6 Homo sapiens 5200 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649702 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649702&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230376 494494546 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372474 Oc1c(F)cc(NC(=O)c2ncc(s2)-c2ccccc2)cc1C=O InChI=1S/C17H11FN2O3S/c18-13-7-12(6-11(9-21)15(13)22)20-16(23)17-19-8-14(24-17)10-4-2-1-3-5-10/h1-9,22H,(H,20,23) JAXUFJVCSIBSFV-UHFFFAOYSA-N 649703 N-(3-fluoro-5-formyl-4- hydroxyphenyl)-5- phenylthiazole-2-carboxamide::US20240043395, Compound 10 Toll-like receptor 2 Homo sapiens 1600 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649703 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649703&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230353 494494547 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372475 Oc1c(F)cc(NC(=O)c2ncc(s2)-c2ccccc2)cc1C=O InChI=1S/C17H11FN2O3S/c18-13-7-12(6-11(9-21)15(13)22)20-16(23)17-19-8-14(24-17)10-4-2-1-3-5-10/h1-9,22H,(H,20,23) JAXUFJVCSIBSFV-UHFFFAOYSA-N 649703 N-(3-fluoro-5-formyl-4- hydroxyphenyl)-5- phenylthiazole-2-carboxamide::US20240043395, Compound 10 Toll-like receptor 6 Homo sapiens 900 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649703 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649703&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230353 494494547 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372476 Oc1c(F)cc(NC(=O)c2ncc(s2)-c2ccccc2)cc1C=O InChI=1S/C17H11FN2O3S/c18-13-7-12(6-11(9-21)15(13)22)20-16(23)17-19-8-14(24-17)10-4-2-1-3-5-10/h1-9,22H,(H,20,23) JAXUFJVCSIBSFV-UHFFFAOYSA-N 649703 N-(3-fluoro-5-formyl-4- hydroxyphenyl)-5- phenylthiazole-2-carboxamide::US20240043395, Compound 10 Toll-like receptor 9 Homo sapiens 1000 US Patent 10.7270/Q2F47T9N aid1963364 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649703 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9962&target=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649703&enzyme=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search 163230353 494494547 1 MGFCRSALHPLSLLVQAIMLAMTLALGTLPAFLPCELQPHGLVNCNWLFLKSVPHFSMAAPRGNVTSLSLSSNRIHHLHDSDFAHLPSLRHLNLKWNCPPVGLSPMHFPCHMTIEPSTFLAVPTLEELNLSYNNIMTVPALPKSLISLSLSHTNILMLDSASLAGLHALRFLFMDGNCYYKNPCRQALEVAPGALLGLGNLTHLSLKYNNLTVVPRNLPSSLEYLLLSYNRIVKLAPEDLANLTALRVLDVGGNCRRCDHAPNPCMECPRHFPQLHPDTFSHLSRLEGLVLKDSSLSWLNASWFRGLGNLRVLDLSENFLYKCITKTKAFQGLTQLRKLNLSFNYQKRVSFAHLSLAPSFGSLVALKELDMHGIFFRSLDETTLRPLARLPMLQTLRLQMNFINQAQLGIFRAFPGLRYVDLSDNRISGASELTATMGEADGGEKVWLQPGDLAPAPVDTPSSEDFRPNCSTLNFTLDLSRNNLVTVQPEMFAQLSHLQCLRLSHNCISQAVNGSQFLPLTGLQVLDLSHNKLDLYHEHSFTELPRLEALDLSYNSQPFGMQGVGHNFSFVAHLRTLRHLSLAHNNIHSQVSQQLCSTSLRALDFSGNALGHMWAEGDLYLHFFQGLSGLIWLDLSQNRLHTLLPQTLRNLPKSLQVLRLRDNYLAFFKWWSLHFLPKLEVLDLAGNQLKALTNGSLPAGTRLRRLDVSCNSISFVAPGFFSKAKELRELNLSANALKTVDHSWFGPLASALQILDVSANPLHCACGAAFMDFLLEVQAAVPGLPSRVKCGSPGQLQGLSIFAQDLRLCLDEALSWDCFALSLLAVALGLGVPMLHHLCGWDLWYCFHLCLAWLPWRGRQSGRDEDALPYDAFVVFDKTQSAVADWVYNELRGQLEECRGRWALRLCLEERDWLPGKTLFENLWASVYGSRKTLFVLAHTDRVSGLLRASFLLAQQRLLEDRKDVVVLVILSPDGRRSRYVRLRQRLCRQSVLLWPHQPSGQRSFWAQLGMALTRDNHHFYNRNFCQGPTAE 8AR3 Toll-like receptor 9 TLR9_HUMAN Q9NR96 B3Y661 D1CS56 Q6UVZ2 Q9HD68 Q9HD69 Q9HD70 Q9NYC2 Q9NYC3 1372477 Oc1c(F)cc(cc1C=O)C(=O)Nc1ncc(s1)-c1ccc(F)cc1 InChI=1S/C17H10F2N2O3S/c18-12-3-1-9(2-4-12)14-7-20-17(25-14)21-16(24)10-5-11(8-22)15(23)13(19)6-10/h1-8,23H,(H,20,21,24) MZBPJXCTMRNEKE-UHFFFAOYSA-N 649704 3-fluoro-N-(5-(4- fluorophenyl)thiazol-2-yl)-5- formyl-4-hydroxybenzamide::US20240043395, Compound 11 Toll-like receptor 2 Homo sapiens 1000 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649704 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649704&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230044 494494548 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372478 Oc1c(F)cc(cc1C=O)C(=O)Nc1ncc(s1)-c1ccc(F)cc1 InChI=1S/C17H10F2N2O3S/c18-12-3-1-9(2-4-12)14-7-20-17(25-14)21-16(24)10-5-11(8-22)15(23)13(19)6-10/h1-8,23H,(H,20,21,24) MZBPJXCTMRNEKE-UHFFFAOYSA-N 649704 3-fluoro-N-(5-(4- fluorophenyl)thiazol-2-yl)-5- formyl-4-hydroxybenzamide::US20240043395, Compound 11 Toll-like receptor 6 Homo sapiens 700 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649704 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649704&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230044 494494548 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372479 Oc1c(F)cc(cc1C=O)C(=O)Nc1ncc(s1)-c1ccc(F)cc1 InChI=1S/C17H10F2N2O3S/c18-12-3-1-9(2-4-12)14-7-20-17(25-14)21-16(24)10-5-11(8-22)15(23)13(19)6-10/h1-8,23H,(H,20,21,24) MZBPJXCTMRNEKE-UHFFFAOYSA-N 649704 3-fluoro-N-(5-(4- fluorophenyl)thiazol-2-yl)-5- formyl-4-hydroxybenzamide::US20240043395, Compound 11 Toll-like receptor 9 Homo sapiens 400 US Patent 10.7270/Q2F47T9N aid1963364 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649704 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9962&target=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649704&enzyme=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search 163230044 494494548 1 MGFCRSALHPLSLLVQAIMLAMTLALGTLPAFLPCELQPHGLVNCNWLFLKSVPHFSMAAPRGNVTSLSLSSNRIHHLHDSDFAHLPSLRHLNLKWNCPPVGLSPMHFPCHMTIEPSTFLAVPTLEELNLSYNNIMTVPALPKSLISLSLSHTNILMLDSASLAGLHALRFLFMDGNCYYKNPCRQALEVAPGALLGLGNLTHLSLKYNNLTVVPRNLPSSLEYLLLSYNRIVKLAPEDLANLTALRVLDVGGNCRRCDHAPNPCMECPRHFPQLHPDTFSHLSRLEGLVLKDSSLSWLNASWFRGLGNLRVLDLSENFLYKCITKTKAFQGLTQLRKLNLSFNYQKRVSFAHLSLAPSFGSLVALKELDMHGIFFRSLDETTLRPLARLPMLQTLRLQMNFINQAQLGIFRAFPGLRYVDLSDNRISGASELTATMGEADGGEKVWLQPGDLAPAPVDTPSSEDFRPNCSTLNFTLDLSRNNLVTVQPEMFAQLSHLQCLRLSHNCISQAVNGSQFLPLTGLQVLDLSHNKLDLYHEHSFTELPRLEALDLSYNSQPFGMQGVGHNFSFVAHLRTLRHLSLAHNNIHSQVSQQLCSTSLRALDFSGNALGHMWAEGDLYLHFFQGLSGLIWLDLSQNRLHTLLPQTLRNLPKSLQVLRLRDNYLAFFKWWSLHFLPKLEVLDLAGNQLKALTNGSLPAGTRLRRLDVSCNSISFVAPGFFSKAKELRELNLSANALKTVDHSWFGPLASALQILDVSANPLHCACGAAFMDFLLEVQAAVPGLPSRVKCGSPGQLQGLSIFAQDLRLCLDEALSWDCFALSLLAVALGLGVPMLHHLCGWDLWYCFHLCLAWLPWRGRQSGRDEDALPYDAFVVFDKTQSAVADWVYNELRGQLEECRGRWALRLCLEERDWLPGKTLFENLWASVYGSRKTLFVLAHTDRVSGLLRASFLLAQQRLLEDRKDVVVLVILSPDGRRSRYVRLRQRLCRQSVLLWPHQPSGQRSFWAQLGMALTRDNHHFYNRNFCQGPTAE 8AR3 Toll-like receptor 9 TLR9_HUMAN Q9NR96 B3Y661 D1CS56 Q6UVZ2 Q9HD68 Q9HD69 Q9HD70 Q9NYC2 Q9NYC3 1372480 Oc1c(F)cc(cc1C=O)C(=O)Nc1ncc(s1)-c1cccc(c1)N1CCCC1 InChI=1S/C21H18FN3O3S/c22-17-10-14(8-15(12-26)19(17)27)20(28)24-21-23-11-18(29-21)13-4-3-5-16(9-13)25-6-1-2-7-25/h3-5,8-12,27H,1-2,6-7H2,(H,23,24,28) WRBCJFIKTXONAZ-UHFFFAOYSA-N 649705 3-fluoro-5-formyl-4-hydroxy- N-(5-(3-(pyrrolidin-1- yl)phenyl)thiazol-2- yl)benzamide::US20240043395, Compound 12 Toll-like receptor 2 Homo sapiens 600 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649705 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649705&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230100 494494549 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372481 Oc1c(F)cc(cc1C=O)C(=O)Nc1ncc(s1)-c1cccc(c1)N1CCCC1 InChI=1S/C21H18FN3O3S/c22-17-10-14(8-15(12-26)19(17)27)20(28)24-21-23-11-18(29-21)13-4-3-5-16(9-13)25-6-1-2-7-25/h3-5,8-12,27H,1-2,6-7H2,(H,23,24,28) WRBCJFIKTXONAZ-UHFFFAOYSA-N 649705 3-fluoro-5-formyl-4-hydroxy- N-(5-(3-(pyrrolidin-1- yl)phenyl)thiazol-2- yl)benzamide::US20240043395, Compound 12 Toll-like receptor 6 Homo sapiens 600 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649705 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649705&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230100 494494549 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372482 Oc1c(F)cc(cc1C=O)C(=O)Nc1ncc(s1)-c1cccc(c1)N1CCCC1 InChI=1S/C21H18FN3O3S/c22-17-10-14(8-15(12-26)19(17)27)20(28)24-21-23-11-18(29-21)13-4-3-5-16(9-13)25-6-1-2-7-25/h3-5,8-12,27H,1-2,6-7H2,(H,23,24,28) WRBCJFIKTXONAZ-UHFFFAOYSA-N 649705 3-fluoro-5-formyl-4-hydroxy- N-(5-(3-(pyrrolidin-1- yl)phenyl)thiazol-2- yl)benzamide::US20240043395, Compound 12 Toll-like receptor 9 Homo sapiens 200 US Patent 10.7270/Q2F47T9N aid1963364 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649705 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9962&target=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649705&enzyme=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search 163230100 494494549 1 MGFCRSALHPLSLLVQAIMLAMTLALGTLPAFLPCELQPHGLVNCNWLFLKSVPHFSMAAPRGNVTSLSLSSNRIHHLHDSDFAHLPSLRHLNLKWNCPPVGLSPMHFPCHMTIEPSTFLAVPTLEELNLSYNNIMTVPALPKSLISLSLSHTNILMLDSASLAGLHALRFLFMDGNCYYKNPCRQALEVAPGALLGLGNLTHLSLKYNNLTVVPRNLPSSLEYLLLSYNRIVKLAPEDLANLTALRVLDVGGNCRRCDHAPNPCMECPRHFPQLHPDTFSHLSRLEGLVLKDSSLSWLNASWFRGLGNLRVLDLSENFLYKCITKTKAFQGLTQLRKLNLSFNYQKRVSFAHLSLAPSFGSLVALKELDMHGIFFRSLDETTLRPLARLPMLQTLRLQMNFINQAQLGIFRAFPGLRYVDLSDNRISGASELTATMGEADGGEKVWLQPGDLAPAPVDTPSSEDFRPNCSTLNFTLDLSRNNLVTVQPEMFAQLSHLQCLRLSHNCISQAVNGSQFLPLTGLQVLDLSHNKLDLYHEHSFTELPRLEALDLSYNSQPFGMQGVGHNFSFVAHLRTLRHLSLAHNNIHSQVSQQLCSTSLRALDFSGNALGHMWAEGDLYLHFFQGLSGLIWLDLSQNRLHTLLPQTLRNLPKSLQVLRLRDNYLAFFKWWSLHFLPKLEVLDLAGNQLKALTNGSLPAGTRLRRLDVSCNSISFVAPGFFSKAKELRELNLSANALKTVDHSWFGPLASALQILDVSANPLHCACGAAFMDFLLEVQAAVPGLPSRVKCGSPGQLQGLSIFAQDLRLCLDEALSWDCFALSLLAVALGLGVPMLHHLCGWDLWYCFHLCLAWLPWRGRQSGRDEDALPYDAFVVFDKTQSAVADWVYNELRGQLEECRGRWALRLCLEERDWLPGKTLFENLWASVYGSRKTLFVLAHTDRVSGLLRASFLLAQQRLLEDRKDVVVLVILSPDGRRSRYVRLRQRLCRQSVLLWPHQPSGQRSFWAQLGMALTRDNHHFYNRNFCQGPTAE 8AR3 Toll-like receptor 9 TLR9_HUMAN Q9NR96 B3Y661 D1CS56 Q6UVZ2 Q9HD68 Q9HD69 Q9HD70 Q9NYC2 Q9NYC3 1372483 Oc1c(F)cc(cc1C=O)C(=O)Nc1ncc(s1)-c1ccc(cc1)N1CCCC1 InChI=1S/C21H18FN3O3S/c22-17-10-14(9-15(12-26)19(17)27)20(28)24-21-23-11-18(29-21)13-3-5-16(6-4-13)25-7-1-2-8-25/h3-6,9-12,27H,1-2,7-8H2,(H,23,24,28) JZIODPUEVVKKOW-UHFFFAOYSA-N 649706 3-fluoro-5-formyl-4-hydroxy- N-(5-(4-(pyrrolidin-1- yl)phenyl)thiazol-2- yl)benzamide::US20240043395, Compound 13 Toll-like receptor 2 Homo sapiens 1500 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649706 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649706&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230388 494494550 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372484 Oc1c(F)cc(cc1C=O)C(=O)Nc1ncc(s1)-c1ccc(cc1)N1CCCC1 InChI=1S/C21H18FN3O3S/c22-17-10-14(9-15(12-26)19(17)27)20(28)24-21-23-11-18(29-21)13-3-5-16(6-4-13)25-7-1-2-8-25/h3-6,9-12,27H,1-2,7-8H2,(H,23,24,28) JZIODPUEVVKKOW-UHFFFAOYSA-N 649706 3-fluoro-5-formyl-4-hydroxy- N-(5-(4-(pyrrolidin-1- yl)phenyl)thiazol-2- yl)benzamide::US20240043395, Compound 13 Toll-like receptor 6 Homo sapiens 1000 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649706 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649706&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230388 494494550 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372485 Oc1c(F)cc(cc1C=O)C(=O)c1ccc(cc1)N1CCCC1 InChI=1S/C18H16FNO3/c19-16-10-13(9-14(11-21)18(16)23)17(22)12-3-5-15(6-4-12)20-7-1-2-8-20/h3-6,9-11,23H,1-2,7-8H2 QPQOHBXIAMOTEP-UHFFFAOYSA-N 649707 3-fluoro-2-hydroxy-5-(4- (pyrrolidin-1- yl)benzoyl)benzaldehyde::US20240043395, Compound 14 Toll-like receptor 2 Homo sapiens 18200 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649707 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649707&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163229969 494494551 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372486 Oc1c(F)cc(cc1C=O)C(=O)c1ccc(cc1)N1CCCC1 InChI=1S/C18H16FNO3/c19-16-10-13(9-14(11-21)18(16)23)17(22)12-3-5-15(6-4-12)20-7-1-2-8-20/h3-6,9-11,23H,1-2,7-8H2 QPQOHBXIAMOTEP-UHFFFAOYSA-N 649707 3-fluoro-2-hydroxy-5-(4- (pyrrolidin-1- yl)benzoyl)benzaldehyde::US20240043395, Compound 14 Toll-like receptor 6 Homo sapiens 18700 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649707 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649707&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163229969 494494551 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372487 Oc1c(F)cc(cc1C=O)C(=O)Nc1coc(n1)-c1ccccc1 InChI=1S/C17H11FN2O4/c18-13-7-11(6-12(8-21)15(13)22)16(23)19-14-9-24-17(20-14)10-4-2-1-3-5-10/h1-9,22H,(H,19,23) CONTVZIBAYQGIN-UHFFFAOYSA-N 649708 3-fluoro-5-formyl-4-hydroxy- N-(2-phenyloxazol-4- yl)benzamide::US20240043395, Compound 15 Toll-like receptor 2 Homo sapiens 4100 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649708 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649708&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230207 494494552 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372488 Oc1c(F)cc(cc1C=O)C(=O)Nc1coc(n1)-c1ccccc1 InChI=1S/C17H11FN2O4/c18-13-7-11(6-12(8-21)15(13)22)16(23)19-14-9-24-17(20-14)10-4-2-1-3-5-10/h1-9,22H,(H,19,23) CONTVZIBAYQGIN-UHFFFAOYSA-N 649708 3-fluoro-5-formyl-4-hydroxy- N-(2-phenyloxazol-4- yl)benzamide::US20240043395, Compound 15 Toll-like receptor 6 Homo sapiens 900 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649708 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649708&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230207 494494552 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372489 COc1cc(cc(F)c1O)-c1scnc1-c1ccccc1 InChI=1S/C16H12FNO2S/c1-20-13-8-11(7-12(17)15(13)19)16-14(18-9-21-16)10-5-3-2-4-6-10/h2-9,19H,1H3 NSKWNMYTKDUUDP-UHFFFAOYSA-N 649709 3-fluoro-2-hydroxy-5-(4- phenylthiazol-5- yl)benzaldehyde::US20240043395, Compound 18 Toll-like receptor 2 Homo sapiens 22200 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649709 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649709&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 170687974 494494553 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372490 COc1cc(cc(F)c1O)-c1scnc1-c1ccccc1 InChI=1S/C16H12FNO2S/c1-20-13-8-11(7-12(17)15(13)19)16-14(18-9-21-16)10-5-3-2-4-6-10/h2-9,19H,1H3 NSKWNMYTKDUUDP-UHFFFAOYSA-N 649709 3-fluoro-2-hydroxy-5-(4- phenylthiazol-5- yl)benzaldehyde::US20240043395, Compound 18 Toll-like receptor 6 Homo sapiens 20300 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649709 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649709&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 170687974 494494553 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372491 COc1cc(cc(F)c1O)C(=O)Nc1cnc(N2CCCC2)c(c1)C(F)(F)F InChI=1S/C18H17F4N3O3/c1-28-14-7-10(6-13(19)15(14)26)17(27)24-11-8-12(18(20,21)22)16(23-9-11)25-4-2-3-5-25/h6-9,26H,2-5H2,1H3,(H,24,27) CFPIBJMMFYBQTH-UHFFFAOYSA-N 649710 3-fluoro-5-formyl-4-hydroxy- N-(6-(pyrrolidin-1-yl)-5- (trifluoromethyl)pyridin-3- yl)benzamide::US20240043395, Compound 19 Toll-like receptor 2 Homo sapiens 400 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649710 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649710&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 170688004 494494554 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372492 COc1cc(cc(F)c1O)C(=O)Nc1cnc(N2CCCC2)c(c1)C(F)(F)F InChI=1S/C18H17F4N3O3/c1-28-14-7-10(6-13(19)15(14)26)17(27)24-11-8-12(18(20,21)22)16(23-9-11)25-4-2-3-5-25/h6-9,26H,2-5H2,1H3,(H,24,27) CFPIBJMMFYBQTH-UHFFFAOYSA-N 649710 3-fluoro-5-formyl-4-hydroxy- N-(6-(pyrrolidin-1-yl)-5- (trifluoromethyl)pyridin-3- yl)benzamide::US20240043395, Compound 19 Toll-like receptor 6 Homo sapiens 300 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649710 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649710&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 170688004 494494554 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372493 COc1cc(cc(F)c1O)C(=O)Nc1cnc(N2CCCC2)c(c1)C(F)(F)F InChI=1S/C18H17F4N3O3/c1-28-14-7-10(6-13(19)15(14)26)17(27)24-11-8-12(18(20,21)22)16(23-9-11)25-4-2-3-5-25/h6-9,26H,2-5H2,1H3,(H,24,27) CFPIBJMMFYBQTH-UHFFFAOYSA-N 649710 3-fluoro-5-formyl-4-hydroxy- N-(6-(pyrrolidin-1-yl)-5- (trifluoromethyl)pyridin-3- yl)benzamide::US20240043395, Compound 19 Toll-like receptor 9 Homo sapiens 600 US Patent 10.7270/Q2F47T9N aid1963364 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649710 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9962&target=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649710&enzyme=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search 170688004 494494554 1 MGFCRSALHPLSLLVQAIMLAMTLALGTLPAFLPCELQPHGLVNCNWLFLKSVPHFSMAAPRGNVTSLSLSSNRIHHLHDSDFAHLPSLRHLNLKWNCPPVGLSPMHFPCHMTIEPSTFLAVPTLEELNLSYNNIMTVPALPKSLISLSLSHTNILMLDSASLAGLHALRFLFMDGNCYYKNPCRQALEVAPGALLGLGNLTHLSLKYNNLTVVPRNLPSSLEYLLLSYNRIVKLAPEDLANLTALRVLDVGGNCRRCDHAPNPCMECPRHFPQLHPDTFSHLSRLEGLVLKDSSLSWLNASWFRGLGNLRVLDLSENFLYKCITKTKAFQGLTQLRKLNLSFNYQKRVSFAHLSLAPSFGSLVALKELDMHGIFFRSLDETTLRPLARLPMLQTLRLQMNFINQAQLGIFRAFPGLRYVDLSDNRISGASELTATMGEADGGEKVWLQPGDLAPAPVDTPSSEDFRPNCSTLNFTLDLSRNNLVTVQPEMFAQLSHLQCLRLSHNCISQAVNGSQFLPLTGLQVLDLSHNKLDLYHEHSFTELPRLEALDLSYNSQPFGMQGVGHNFSFVAHLRTLRHLSLAHNNIHSQVSQQLCSTSLRALDFSGNALGHMWAEGDLYLHFFQGLSGLIWLDLSQNRLHTLLPQTLRNLPKSLQVLRLRDNYLAFFKWWSLHFLPKLEVLDLAGNQLKALTNGSLPAGTRLRRLDVSCNSISFVAPGFFSKAKELRELNLSANALKTVDHSWFGPLASALQILDVSANPLHCACGAAFMDFLLEVQAAVPGLPSRVKCGSPGQLQGLSIFAQDLRLCLDEALSWDCFALSLLAVALGLGVPMLHHLCGWDLWYCFHLCLAWLPWRGRQSGRDEDALPYDAFVVFDKTQSAVADWVYNELRGQLEECRGRWALRLCLEERDWLPGKTLFENLWASVYGSRKTLFVLAHTDRVSGLLRASFLLAQQRLLEDRKDVVVLVILSPDGRRSRYVRLRQRLCRQSVLLWPHQPSGQRSFWAQLGMALTRDNHHFYNRNFCQGPTAE 8AR3 Toll-like receptor 9 TLR9_HUMAN Q9NR96 B3Y661 D1CS56 Q6UVZ2 Q9HD68 Q9HD69 Q9HD70 Q9NYC2 Q9NYC3 1372494 Oc1c(F)cc(cc1C=O)C(=O)N1CCC(CC1)c1ccc(cc1)N1CCCC1 InChI=1S/C23H25FN2O3/c24-21-14-18(13-19(15-27)22(21)28)23(29)26-11-7-17(8-12-26)16-3-5-20(6-4-16)25-9-1-2-10-25/h3-6,13-15,17,28H,1-2,7-12H2 CPNWAKUSEQNAFO-UHFFFAOYSA-N 649711 3-fluoro-2-hydroxy-5-(4-(4- (pyrrolidin-1- yl)phenyl)piperidine-1- carbonyl)benzaldehyde::US20240043395, Compound 34 Toll-like receptor 2 Homo sapiens 900 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649711 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649711&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230350 494494555 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372495 Oc1c(F)cc(cc1C=O)C(=O)N1CCC(CC1)c1ccc(cc1)N1CCCC1 InChI=1S/C23H25FN2O3/c24-21-14-18(13-19(15-27)22(21)28)23(29)26-11-7-17(8-12-26)16-3-5-20(6-4-16)25-9-1-2-10-25/h3-6,13-15,17,28H,1-2,7-12H2 CPNWAKUSEQNAFO-UHFFFAOYSA-N 649711 3-fluoro-2-hydroxy-5-(4-(4- (pyrrolidin-1- yl)phenyl)piperidine-1- carbonyl)benzaldehyde::US20240043395, Compound 34 Toll-like receptor 6 Homo sapiens 400 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649711 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649711&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230350 494494555 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372496 Oc1c(F)cc(cc1C=O)C(=O)N1CCC(CC1)c1cccc(c1)N1CCCC1 InChI=1S/C23H25FN2O3/c24-21-14-18(12-19(15-27)22(21)28)23(29)26-10-6-16(7-11-26)17-4-3-5-20(13-17)25-8-1-2-9-25/h3-5,12-16,28H,1-2,6-11H2 KHNHZWNZYDQCHI-UHFFFAOYSA-N 649712 3-fluoro-2-hydroxy-5-(4-(3- (pyrrolidin-1- yl)phenyl)piperidine-1- carbonyl)benzaldehyde::US20240043395, Compound 35 Toll-like receptor 2 Homo sapiens 13800 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649712 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649712&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230004 494494556 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372497 Oc1c(F)cc(cc1C=O)C(=O)N1CCC(CC1)c1cccc(c1)N1CCCC1 InChI=1S/C23H25FN2O3/c24-21-14-18(12-19(15-27)22(21)28)23(29)26-10-6-16(7-11-26)17-4-3-5-20(13-17)25-8-1-2-9-25/h3-5,12-16,28H,1-2,6-11H2 KHNHZWNZYDQCHI-UHFFFAOYSA-N 649712 3-fluoro-2-hydroxy-5-(4-(3- (pyrrolidin-1- yl)phenyl)piperidine-1- carbonyl)benzaldehyde::US20240043395, Compound 35 Toll-like receptor 6 Homo sapiens 8000 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649712 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649712&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230004 494494556 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372498 Oc1c(F)cc(cc1C=O)C(=O)N1CCC(CC1)c1ccnc(c1)N1CCCC1 InChI=1S/C22H24FN3O3/c23-19-12-17(11-18(14-27)21(19)28)22(29)26-9-4-15(5-10-26)16-3-6-24-20(13-16)25-7-1-2-8-25/h3,6,11-15,28H,1-2,4-5,7-10H2 FPTSURMNKMYCSM-UHFFFAOYSA-N 649713 3-fluoro-2-hydroxy-5-(4-(2- (pyrrolidin-1-yl)pyridin-4- yl)piperidine-1- carbonyl)benzaldehyde::US20240043395, Compound 36 Toll-like receptor 2 Homo sapiens 17400 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649713 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649713&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230001 494494557 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372499 Oc1c(F)cc(cc1C=O)C(=O)N1CCC(CC1)c1ccnc(c1)N1CCCC1 InChI=1S/C22H24FN3O3/c23-19-12-17(11-18(14-27)21(19)28)22(29)26-9-4-15(5-10-26)16-3-6-24-20(13-16)25-7-1-2-8-25/h3,6,11-15,28H,1-2,4-5,7-10H2 FPTSURMNKMYCSM-UHFFFAOYSA-N 649713 3-fluoro-2-hydroxy-5-(4-(2- (pyrrolidin-1-yl)pyridin-4- yl)piperidine-1- carbonyl)benzaldehyde::US20240043395, Compound 36 Toll-like receptor 6 Homo sapiens 15100 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649713 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649713&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230001 494494557 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372500 Oc1c(F)cc(cc1C=O)C(=O)N1CCC(CC1)c1ccc(nc1)N1CCCC1 InChI=1S/C22H24FN3O3/c23-19-12-17(11-18(14-27)21(19)28)22(29)26-9-5-15(6-10-26)16-3-4-20(24-13-16)25-7-1-2-8-25/h3-4,11-15,28H,1-2,5-10H2 SFTRIGYHVVZQAW-UHFFFAOYSA-N 649714 3-fluoro-2-hydroxy-5-(4-(6- (pyrrolidin-1-yl)pyridin-3- yl)piperidine-1- carbonyl)benzaldehyde::US20240043395, Compound 37 Toll-like receptor 2 Homo sapiens 6200 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649714 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649714&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230066 494494558 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372501 Oc1c(F)cc(cc1C=O)C(=O)N1CCC(CC1)c1ccc(nc1)N1CCCC1 InChI=1S/C22H24FN3O3/c23-19-12-17(11-18(14-27)21(19)28)22(29)26-9-5-15(6-10-26)16-3-4-20(24-13-16)25-7-1-2-8-25/h3-4,11-15,28H,1-2,5-10H2 SFTRIGYHVVZQAW-UHFFFAOYSA-N 649714 3-fluoro-2-hydroxy-5-(4-(6- (pyrrolidin-1-yl)pyridin-3- yl)piperidine-1- carbonyl)benzaldehyde::US20240043395, Compound 37 Toll-like receptor 6 Homo sapiens 4800 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649714 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649714&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230066 494494558 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372502 Oc1c(F)cc(cc1C=O)C(=O)N1CCC(C1)c1ccc(cc1)N1CCCC1 InChI=1S/C22H23FN2O3/c23-20-12-17(11-18(14-26)21(20)27)22(28)25-10-7-16(13-25)15-3-5-19(6-4-15)24-8-1-2-9-24/h3-6,11-12,14,16,27H,1-2,7-10,13H2 YMEXYFPTOANDTG-UHFFFAOYSA-N 649715 3-fluoro-2-hydroxy-5-(3-(4- (pyrrolidin-1- yl)phenyl)pyrrolidine-1- carbonyl)benzaldehyde::US20240043395, Compound 82 Toll-like receptor 2 Homo sapiens 8400 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649715 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649715&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230160 494494559 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372503 Oc1c(F)cc(cc1C=O)C(=O)N1CCC(C1)c1ccc(cc1)N1CCCC1 InChI=1S/C22H23FN2O3/c23-20-12-17(11-18(14-26)21(20)27)22(28)25-10-7-16(13-25)15-3-5-19(6-4-15)24-8-1-2-9-24/h3-6,11-12,14,16,27H,1-2,7-10,13H2 YMEXYFPTOANDTG-UHFFFAOYSA-N 649715 3-fluoro-2-hydroxy-5-(3-(4- (pyrrolidin-1- yl)phenyl)pyrrolidine-1- carbonyl)benzaldehyde::US20240043395, Compound 82 Toll-like receptor 6 Homo sapiens 3500 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649715 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649715&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230160 494494559 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372504 Oc1c(F)cc(cc1C=O)C(=O)N1CC(C1)c1ccc(cc1)N1CCCC1 InChI=1S/C21H21FN2O3/c22-19-10-15(9-16(13-25)20(19)26)21(27)24-11-17(12-24)14-3-5-18(6-4-14)23-7-1-2-8-23/h3-6,9-10,13,17,26H,1-2,7-8,11-12H2 JQFGXBUWJMNQLE-UHFFFAOYSA-N 649716 3-fluoro-2-hydroxy-5-(3-(4- (pyrrolidin-1- yl)phenyl)azetidine-1- carbonyl)benzaldehyde::US20240043395, Compound 84 Toll-like receptor 2 Homo sapiens 6200 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649716 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649716&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230288 494494560 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372505 Oc1c(F)cc(cc1C=O)C(=O)N1CC(C1)c1ccc(cc1)N1CCCC1 InChI=1S/C21H21FN2O3/c22-19-10-15(9-16(13-25)20(19)26)21(27)24-11-17(12-24)14-3-5-18(6-4-14)23-7-1-2-8-23/h3-6,9-10,13,17,26H,1-2,7-8,11-12H2 JQFGXBUWJMNQLE-UHFFFAOYSA-N 649716 3-fluoro-2-hydroxy-5-(3-(4- (pyrrolidin-1- yl)phenyl)azetidine-1- carbonyl)benzaldehyde::US20240043395, Compound 84 Toll-like receptor 6 Homo sapiens 3800 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649716 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649716&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230288 494494560 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372506 COc1cc(cc(F)c1O)C(=O)Nc1ccc(nn1)N1CCCC1 InChI=1S/C16H17FN4O3/c1-24-12-9-10(8-11(17)15(12)22)16(23)18-13-4-5-14(20-19-13)21-6-2-3-7-21/h4-5,8-9,22H,2-3,6-7H2,1H3,(H,18,19,23) UZULRMPKNJEPGX-UHFFFAOYSA-N 649717 3-fluoro-5-formyl-4-hydroxy- N-(6-(pyrrolidin-1- yl)pyridazin-3-yl)benzamide::US20240043395, Compound 92 Toll-like receptor 2 Homo sapiens 59000 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649717 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649717&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 170688066 494494561 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372507 COc1cc(cc(F)c1O)C(=O)Nc1ccc(nn1)N1CCCC1 InChI=1S/C16H17FN4O3/c1-24-12-9-10(8-11(17)15(12)22)16(23)18-13-4-5-14(20-19-13)21-6-2-3-7-21/h4-5,8-9,22H,2-3,6-7H2,1H3,(H,18,19,23) UZULRMPKNJEPGX-UHFFFAOYSA-N 649717 3-fluoro-5-formyl-4-hydroxy- N-(6-(pyrrolidin-1- yl)pyridazin-3-yl)benzamide::US20240043395, Compound 92 Toll-like receptor 6 Homo sapiens 39000 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649717 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649717&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 170688066 494494561 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372508 Oc1c(F)cc(cc1C=O)C(=O)N1CCCN(CC1)c1cccc(c1)N1CCCC1 InChI=1S/C23H26FN3O3/c24-21-14-17(13-18(16-28)22(21)29)23(30)27-10-4-9-26(11-12-27)20-6-3-5-19(15-20)25-7-1-2-8-25/h3,5-6,13-16,29H,1-2,4,7-12H2 WFKYHJAAFHPDKD-UHFFFAOYSA-N 649718 3-fluoro-2-hydroxy-5-(4-(3- (pyrrolidin-1-yl)phenyl)-1,4- diazepane-1- carbonyl)benzaldehyde::US20240043395, Compound 98 Toll-like receptor 2 Homo sapiens 15100 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649718 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649718&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230343 494494562 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372509 Oc1c(F)cc(cc1C=O)C(=O)N1CCCN(CC1)c1cccc(c1)N1CCCC1 InChI=1S/C23H26FN3O3/c24-21-14-17(13-18(16-28)22(21)29)23(30)27-10-4-9-26(11-12-27)20-6-3-5-19(15-20)25-7-1-2-8-25/h3,5-6,13-16,29H,1-2,4,7-12H2 WFKYHJAAFHPDKD-UHFFFAOYSA-N 649718 3-fluoro-2-hydroxy-5-(4-(3- (pyrrolidin-1-yl)phenyl)-1,4- diazepane-1- carbonyl)benzaldehyde::US20240043395, Compound 98 Toll-like receptor 6 Homo sapiens 18100 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649718 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649718&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230343 494494562 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372510 Oc1c(F)cc(cc1C=O)C(=O)Nc1ncc(s1)-c1ccc(cc1)C(F)(F)F InChI=1S/C18H10F4N2O3S/c19-13-6-10(5-11(8-25)15(13)26)16(27)24-17-23-7-14(28-17)9-1-3-12(4-2-9)18(20,21)22/h1-8,26H,(H,23,24,27) SNHQEEKVWMSJHE-UHFFFAOYSA-N 649719 3-fluoro-5-formyl-4-hydroxy- N-(5-(4- (trifluoromethyl)phenyl) thiazol-2-yl)benzamide::US20240043395, Compound 115 Toll-like receptor 2 Homo sapiens 1000 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649719 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649719&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230400 494494563 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372511 Oc1c(F)cc(cc1C=O)C(=O)Nc1ncc(s1)-c1ccc(cc1)C(F)(F)F InChI=1S/C18H10F4N2O3S/c19-13-6-10(5-11(8-25)15(13)26)16(27)24-17-23-7-14(28-17)9-1-3-12(4-2-9)18(20,21)22/h1-8,26H,(H,23,24,27) SNHQEEKVWMSJHE-UHFFFAOYSA-N 649719 3-fluoro-5-formyl-4-hydroxy- N-(5-(4- (trifluoromethyl)phenyl) thiazol-2-yl)benzamide::US20240043395, Compound 115 Toll-like receptor 6 Homo sapiens 600 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649719 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649719&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230400 494494563 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372512 COc1cc(cc(F)c1O)C(=O)Nc1nc(ns1)-c1ccccc1 InChI=1S/C16H12FN3O3S/c1-23-12-8-10(7-11(17)13(12)21)15(22)19-16-18-14(20-24-16)9-5-3-2-4-6-9/h2-8,21H,1H3,(H,18,19,20,22) HHCIVTLGUFEHNZ-UHFFFAOYSA-N 649720 3-fluoro-5-formyl-4-hydroxy- N-(3-phenyl-1,2,4-thiadiazol- 5-yl)benzamide::US20240043395, Compound 121 Toll-like receptor 2 Homo sapiens 15900 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649720 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649720&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 170687920 494494564 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372513 COc1cc(cc(F)c1O)C(=O)Nc1nc(ns1)-c1ccccc1 InChI=1S/C16H12FN3O3S/c1-23-12-8-10(7-11(17)13(12)21)15(22)19-16-18-14(20-24-16)9-5-3-2-4-6-9/h2-8,21H,1H3,(H,18,19,20,22) HHCIVTLGUFEHNZ-UHFFFAOYSA-N 649720 3-fluoro-5-formyl-4-hydroxy- N-(3-phenyl-1,2,4-thiadiazol- 5-yl)benzamide::US20240043395, Compound 121 Toll-like receptor 6 Homo sapiens 7900 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649720 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649720&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 170687920 494494564 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372514 COc1cc(cc(F)c1O)-c1cnn(c1)-c1ccc(cc1)C(F)(F)F InChI=1S/C17H12F4N2O2/c1-25-15-7-10(6-14(18)16(15)24)11-8-22-23(9-11)13-4-2-12(3-5-13)17(19,20)21/h2-9,24H,1H3 DZCYGXRMSXMTSC-UHFFFAOYSA-N 649721 3-fluoro-2-hydroxy-5-(1-(4- (trifluoromethyl)phenyl)-1H- pyrazol-4-yl)benzaldehyde::US20240043395, Compound 127 Toll-like receptor 2 Homo sapiens 500 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649721 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649721&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 170688029 494494565 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372515 COc1cc(cc(F)c1O)-c1cnn(c1)-c1ccc(cc1)C(F)(F)F InChI=1S/C17H12F4N2O2/c1-25-15-7-10(6-14(18)16(15)24)11-8-22-23(9-11)13-4-2-12(3-5-13)17(19,20)21/h2-9,24H,1H3 DZCYGXRMSXMTSC-UHFFFAOYSA-N 649721 3-fluoro-2-hydroxy-5-(1-(4- (trifluoromethyl)phenyl)-1H- pyrazol-4-yl)benzaldehyde::US20240043395, Compound 127 Toll-like receptor 6 Homo sapiens 500 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649721 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649721&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 170688029 494494565 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372516 COc1cc(cc(F)c1O)-c1cnn(c1)-c1ccc(cc1)C(F)(F)F InChI=1S/C17H12F4N2O2/c1-25-15-7-10(6-14(18)16(15)24)11-8-22-23(9-11)13-4-2-12(3-5-13)17(19,20)21/h2-9,24H,1H3 DZCYGXRMSXMTSC-UHFFFAOYSA-N 649721 3-fluoro-2-hydroxy-5-(1-(4- (trifluoromethyl)phenyl)-1H- pyrazol-4-yl)benzaldehyde::US20240043395, Compound 127 Toll-like receptor 9 Homo sapiens 100.0 US Patent 10.7270/Q2F47T9N aid1963364 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649721 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9962&target=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649721&enzyme=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search 170688029 494494565 1 MGFCRSALHPLSLLVQAIMLAMTLALGTLPAFLPCELQPHGLVNCNWLFLKSVPHFSMAAPRGNVTSLSLSSNRIHHLHDSDFAHLPSLRHLNLKWNCPPVGLSPMHFPCHMTIEPSTFLAVPTLEELNLSYNNIMTVPALPKSLISLSLSHTNILMLDSASLAGLHALRFLFMDGNCYYKNPCRQALEVAPGALLGLGNLTHLSLKYNNLTVVPRNLPSSLEYLLLSYNRIVKLAPEDLANLTALRVLDVGGNCRRCDHAPNPCMECPRHFPQLHPDTFSHLSRLEGLVLKDSSLSWLNASWFRGLGNLRVLDLSENFLYKCITKTKAFQGLTQLRKLNLSFNYQKRVSFAHLSLAPSFGSLVALKELDMHGIFFRSLDETTLRPLARLPMLQTLRLQMNFINQAQLGIFRAFPGLRYVDLSDNRISGASELTATMGEADGGEKVWLQPGDLAPAPVDTPSSEDFRPNCSTLNFTLDLSRNNLVTVQPEMFAQLSHLQCLRLSHNCISQAVNGSQFLPLTGLQVLDLSHNKLDLYHEHSFTELPRLEALDLSYNSQPFGMQGVGHNFSFVAHLRTLRHLSLAHNNIHSQVSQQLCSTSLRALDFSGNALGHMWAEGDLYLHFFQGLSGLIWLDLSQNRLHTLLPQTLRNLPKSLQVLRLRDNYLAFFKWWSLHFLPKLEVLDLAGNQLKALTNGSLPAGTRLRRLDVSCNSISFVAPGFFSKAKELRELNLSANALKTVDHSWFGPLASALQILDVSANPLHCACGAAFMDFLLEVQAAVPGLPSRVKCGSPGQLQGLSIFAQDLRLCLDEALSWDCFALSLLAVALGLGVPMLHHLCGWDLWYCFHLCLAWLPWRGRQSGRDEDALPYDAFVVFDKTQSAVADWVYNELRGQLEECRGRWALRLCLEERDWLPGKTLFENLWASVYGSRKTLFVLAHTDRVSGLLRASFLLAQQRLLEDRKDVVVLVILSPDGRRSRYVRLRQRLCRQSVLLWPHQPSGQRSFWAQLGMALTRDNHHFYNRNFCQGPTAE 8AR3 Toll-like receptor 9 TLR9_HUMAN Q9NR96 B3Y661 D1CS56 Q6UVZ2 Q9HD68 Q9HD69 Q9HD70 Q9NYC2 Q9NYC3 1372517 COc1cc(cc(OC)c1O)-c1cnn(c1)-c1ccc(cc1)C(F)(F)F InChI=1S/C18H15F3N2O3/c1-25-15-7-11(8-16(26-2)17(15)24)12-9-22-23(10-12)14-5-3-13(4-6-14)18(19,20)21/h3-10,24H,1-2H3 YVXGWCCIBZMQEC-UHFFFAOYSA-N 649722 2-hydroxy-3-methoxy-5-(1-(4- (trifluoromethyl)phenyl)-1H- pyrazol-4-yl)benzaldehyde::US20240043395, Compound 128 Toll-like receptor 2 Homo sapiens 700 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649722 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649722&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 171362302 494494566 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372518 COc1cc(cc(OC)c1O)-c1cnn(c1)-c1ccc(cc1)C(F)(F)F InChI=1S/C18H15F3N2O3/c1-25-15-7-11(8-16(26-2)17(15)24)12-9-22-23(10-12)14-5-3-13(4-6-14)18(19,20)21/h3-10,24H,1-2H3 YVXGWCCIBZMQEC-UHFFFAOYSA-N 649722 2-hydroxy-3-methoxy-5-(1-(4- (trifluoromethyl)phenyl)-1H- pyrazol-4-yl)benzaldehyde::US20240043395, Compound 128 Toll-like receptor 6 Homo sapiens 800 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649722 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649722&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 171362302 494494566 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372519 Oc1cnc(cc1C=O)-c1cnc(s1)-c1ccc(nc1)N1CCCC1 InChI=1S/C18H16N4O2S/c23-11-13-7-14(19-9-15(13)24)16-10-21-18(25-16)12-3-4-17(20-8-12)22-5-1-2-6-22/h3-4,7-11,24H,1-2,5-6H2 YDZVFBDCUXVBDN-UHFFFAOYSA-N 649723 5-hydroxy-2-(2-(6-(pyrrolidin- 1-yl)pyridin-3-yl)thiazol-5- yl)isonicotinaldehyde::US20240043395, Compound 129 Toll-like receptor 2 Homo sapiens 700 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649723 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649723&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230402 494494567 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372520 Oc1cnc(cc1C=O)-c1cnc(s1)-c1ccc(nc1)N1CCCC1 InChI=1S/C18H16N4O2S/c23-11-13-7-14(19-9-15(13)24)16-10-21-18(25-16)12-3-4-17(20-8-12)22-5-1-2-6-22/h3-4,7-11,24H,1-2,5-6H2 YDZVFBDCUXVBDN-UHFFFAOYSA-N 649723 5-hydroxy-2-(2-(6-(pyrrolidin- 1-yl)pyridin-3-yl)thiazol-5- yl)isonicotinaldehyde::US20240043395, Compound 129 Toll-like receptor 6 Homo sapiens 400 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649723 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649723&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230402 494494567 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372521 Oc1c(F)cc(cc1C=O)-c1nc(ns1)-c1ccc(nc1)N1CCCC1 InChI=1S/C18H15FN4O2S/c19-14-8-12(7-13(10-24)16(14)25)18-21-17(22-26-18)11-3-4-15(20-9-11)23-5-1-2-6-23/h3-4,7-10,25H,1-2,5-6H2 DEAWQSBYFLWHIN-UHFFFAOYSA-N 649724 3-fluoro-2-hydroxy-5-(3-(6- (pyrrolidin-1-yl)pyridin-3-yl)- 1,2,4-thiadiazol-5- yl)benzaldehyde::US20240043395, Compound 130 Toll-like receptor 2 Homo sapiens 1300 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649724 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649724&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230334 494494568 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372522 Oc1c(F)cc(cc1C=O)-c1nc(ns1)-c1ccc(nc1)N1CCCC1 InChI=1S/C18H15FN4O2S/c19-14-8-12(7-13(10-24)16(14)25)18-21-17(22-26-18)11-3-4-15(20-9-11)23-5-1-2-6-23/h3-4,7-10,25H,1-2,5-6H2 DEAWQSBYFLWHIN-UHFFFAOYSA-N 649724 3-fluoro-2-hydroxy-5-(3-(6- (pyrrolidin-1-yl)pyridin-3-yl)- 1,2,4-thiadiazol-5- yl)benzaldehyde::US20240043395, Compound 130 Toll-like receptor 6 Homo sapiens 800 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649724 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649724&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230334 494494568 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372523 Oc1c(F)cc(cc1C=O)C(=O)N1CCN(CC1)c1ccc(nc1)N1CCCC1 InChI=1S/C21H23FN4O3/c22-18-12-15(11-16(14-27)20(18)28)21(29)26-9-7-24(8-10-26)17-3-4-19(23-13-17)25-5-1-2-6-25/h3-4,11-14,28H,1-2,5-10H2 XESXHKQFXVHPPW-UHFFFAOYSA-N 649725 3-fluoro-2-hydroxy-5-(4-(6- (pyrrolidin-1-yl)pyridin-3- yl)piperazine-1- carbonyl)benzaldehyde::US20240043395, Compound 140 Toll-like receptor 2 Homo sapiens 14000 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649725 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649725&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230143 494494569 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372524 Oc1c(F)cc(cc1C=O)C(=O)N1CCN(CC1)c1ccc(nc1)N1CCCC1 InChI=1S/C21H23FN4O3/c22-18-12-15(11-16(14-27)20(18)28)21(29)26-9-7-24(8-10-26)17-3-4-19(23-13-17)25-5-1-2-6-25/h3-4,11-14,28H,1-2,5-10H2 XESXHKQFXVHPPW-UHFFFAOYSA-N 649725 3-fluoro-2-hydroxy-5-(4-(6- (pyrrolidin-1-yl)pyridin-3- yl)piperazine-1- carbonyl)benzaldehyde::US20240043395, Compound 140 Toll-like receptor 6 Homo sapiens 7200 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649725 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649725&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230143 494494569 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372525 Oc1c(F)cc(cc1C=O)C(=O)N1CCCN(CC1)c1ccc(nc1)N1CCCC1 InChI=1S/C22H25FN4O3/c23-19-13-16(12-17(15-28)21(19)29)22(30)27-9-3-8-25(10-11-27)18-4-5-20(24-14-18)26-6-1-2-7-26/h4-5,12-15,29H,1-3,6-11H2 PSHBQDIWYJZYEF-UHFFFAOYSA-N 649726 3-fluoro-2-hydroxy-5-(4-(6- (pyrrolidin-1-yl)pyridin-3-yl)- 1,4-diazepane-1- carbonyl)benzaldehyde trifluoroacetate salt::US20240043395, Compound 141 Toll-like receptor 2 Homo sapiens 50400 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649726 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649726&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230012 494494570 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372526 Oc1c(F)cc(cc1C=O)C(=O)N1CCCN(CC1)c1ccc(nc1)N1CCCC1 InChI=1S/C22H25FN4O3/c23-19-13-16(12-17(15-28)21(19)29)22(30)27-9-3-8-25(10-11-27)18-4-5-20(24-14-18)26-6-1-2-7-26/h4-5,12-15,29H,1-3,6-11H2 PSHBQDIWYJZYEF-UHFFFAOYSA-N 649726 3-fluoro-2-hydroxy-5-(4-(6- (pyrrolidin-1-yl)pyridin-3-yl)- 1,4-diazepane-1- carbonyl)benzaldehyde trifluoroacetate salt::US20240043395, Compound 141 Toll-like receptor 6 Homo sapiens 40100 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649726 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649726&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230012 494494570 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372527 Oc1c(F)cc(cc1C=O)C(=O)N1CCC(O)(CC1)c1ccc(nc1)N1CCCC1 InChI=1S/C22H24FN3O4/c23-18-12-15(11-16(14-27)20(18)28)21(29)26-9-5-22(30,6-10-26)17-3-4-19(24-13-17)25-7-1-2-8-25/h3-4,11-14,28,30H,1-2,5-10H2 WDXYRJRFAINXRJ-UHFFFAOYSA-N 649727 3-fluoro-2-hydroxy-5-(4- hydroxy-4-(6-(pyrrolidin-1- yl)pyridin-3-yl)piperidine-1- carbonyl)benzaldehyde::US20240043395, Compound 142 Toll-like receptor 2 Homo sapiens 34200 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649727 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649727&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230309 494494571 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372528 Oc1c(F)cc(cc1C=O)C(=O)N1CCC(O)(CC1)c1ccc(nc1)N1CCCC1 InChI=1S/C22H24FN3O4/c23-18-12-15(11-16(14-27)20(18)28)21(29)26-9-5-22(30,6-10-26)17-3-4-19(24-13-17)25-7-1-2-8-25/h3-4,11-14,28,30H,1-2,5-10H2 WDXYRJRFAINXRJ-UHFFFAOYSA-N 649727 3-fluoro-2-hydroxy-5-(4- hydroxy-4-(6-(pyrrolidin-1- yl)pyridin-3-yl)piperidine-1- carbonyl)benzaldehyde::US20240043395, Compound 142 Toll-like receptor 6 Homo sapiens 34800 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649727 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649727&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230309 494494571 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372529 Oc1c(F)cc(cc1C=O)C(=O)NCCc1ccc(cc1)N1CCCC1 InChI=1S/C20H21FN2O3/c21-18-12-15(11-16(13-24)19(18)25)20(26)22-8-7-14-3-5-17(6-4-14)23-9-1-2-10-23/h3-6,11-13,25H,1-2,7-10H2,(H,22,26) DMLPRDRRVQRDNM-UHFFFAOYSA-N 649728 3-fluoro-5-formyl-4-hydroxy- N-(4-(pyrrolidin-1- yl)phenethyl)benzamide::US20240043395, Compound 143 Toll-like receptor 2 Homo sapiens 17000 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649728 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649728&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230273 494494572 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372530 Oc1c(F)cc(cc1C=O)C(=O)NCCc1ccc(cc1)N1CCCC1 InChI=1S/C20H21FN2O3/c21-18-12-15(11-16(13-24)19(18)25)20(26)22-8-7-14-3-5-17(6-4-14)23-9-1-2-10-23/h3-6,11-13,25H,1-2,7-10H2,(H,22,26) DMLPRDRRVQRDNM-UHFFFAOYSA-N 649728 3-fluoro-5-formyl-4-hydroxy- N-(4-(pyrrolidin-1- yl)phenethyl)benzamide::US20240043395, Compound 143 Toll-like receptor 6 Homo sapiens 12300 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649728 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649728&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230273 494494572 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372531 Oc1c(F)cc(cc1C=O)C(=O)NCCCc1ccc(cc1)N1CCCC1 InChI=1S/C21H23FN2O3/c22-19-13-16(12-17(14-25)20(19)26)21(27)23-9-3-4-15-5-7-18(8-6-15)24-10-1-2-11-24/h5-8,12-14,26H,1-4,9-11H2,(H,23,27) PTXYJJHYURNZHX-UHFFFAOYSA-N 649729 3-fluoro-5-formyl-4-hydroxy- N-(3-(4-(pyrrolidin-1- yl)phenyl)propyl)benzamide::US20240043395, Compound 144 Toll-like receptor 2 Homo sapiens 9300 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649729 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649729&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230390 494494573 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372532 Oc1c(F)cc(cc1C=O)C(=O)NCCCc1ccc(cc1)N1CCCC1 InChI=1S/C21H23FN2O3/c22-19-13-16(12-17(14-25)20(19)26)21(27)23-9-3-4-15-5-7-18(8-6-15)24-10-1-2-11-24/h5-8,12-14,26H,1-4,9-11H2,(H,23,27) PTXYJJHYURNZHX-UHFFFAOYSA-N 649729 3-fluoro-5-formyl-4-hydroxy- N-(3-(4-(pyrrolidin-1- yl)phenyl)propyl)benzamide::US20240043395, Compound 144 Toll-like receptor 6 Homo sapiens 5300 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649729 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649729&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230390 494494573 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372533 Oc1c(F)cc(cc1C=O)C(=O)N1CCC(CC1)c1ccc(cn1)N1CCCC1 InChI=1S/C22H24FN3O3/c23-19-12-16(11-17(14-27)21(19)28)22(29)26-9-5-15(6-10-26)20-4-3-18(13-24-20)25-7-1-2-8-25/h3-4,11-15,28H,1-2,5-10H2 ZEXVWDFLYIVGEM-UHFFFAOYSA-N 649730 3-fluoro-2-hydroxy-5-(4-(5- (pyrrolidin-1-yl)pyridin-2- yl)piperidine-1- carbonyl)benzaldehyde::US20240043395, Compound 145 Toll-like receptor 2 Homo sapiens 6000 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649730 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649730&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163229895 494494574 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372534 Oc1c(F)cc(cc1C=O)C(=O)N1CCC(CC1)c1ccc(cn1)N1CCCC1 InChI=1S/C22H24FN3O3/c23-19-12-16(11-17(14-27)21(19)28)22(29)26-9-5-15(6-10-26)20-4-3-18(13-24-20)25-7-1-2-8-25/h3-4,11-15,28H,1-2,5-10H2 ZEXVWDFLYIVGEM-UHFFFAOYSA-N 649730 3-fluoro-2-hydroxy-5-(4-(5- (pyrrolidin-1-yl)pyridin-2- yl)piperidine-1- carbonyl)benzaldehyde::US20240043395, Compound 145 Toll-like receptor 6 Homo sapiens 4600 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649730 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649730&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163229895 494494574 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372535 Oc1c(F)cc(cc1C=O)C(=O)N1CCC(CC1)c1cccc(n1)N1CCCC1 InChI=1S/C22H24FN3O3/c23-18-13-16(12-17(14-27)21(18)28)22(29)26-10-6-15(7-11-26)19-4-3-5-20(24-19)25-8-1-2-9-25/h3-5,12-15,28H,1-2,6-11H2 PUAUJTRQSSWPTB-UHFFFAOYSA-N 649731 3-fluoro-2-hydroxy-5-(4-(6- (pyrrolidin-1-yl)pyridin-2- yl)piperidine-1- carbonyl)benzaldehyde::US20240043395, Compound 146 Toll-like receptor 2 Homo sapiens 14100 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649731 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649731&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230145 494494575 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372536 Oc1c(F)cc(cc1C=O)C(=O)N1CCC(CC1)c1cccc(n1)N1CCCC1 InChI=1S/C22H24FN3O3/c23-18-13-16(12-17(14-27)21(18)28)22(29)26-10-6-15(7-11-26)19-4-3-5-20(24-19)25-8-1-2-9-25/h3-5,12-15,28H,1-2,6-11H2 PUAUJTRQSSWPTB-UHFFFAOYSA-N 649731 3-fluoro-2-hydroxy-5-(4-(6- (pyrrolidin-1-yl)pyridin-2- yl)piperidine-1- carbonyl)benzaldehyde::US20240043395, Compound 146 Toll-like receptor 6 Homo sapiens 10100 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649731 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649731&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230145 494494575 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372537 Oc1c(F)cc(cc1C=O)C(=O)N1CCOC(C1)c1ccc(cc1)N1CCCC1 InChI=1S/C22H23FN2O4/c23-19-12-16(11-17(14-26)21(19)27)22(28)25-9-10-29-20(13-25)15-3-5-18(6-4-15)24-7-1-2-8-24/h3-6,11-12,14,20,27H,1-2,7-10,13H2 CGOXBCDMYAVXJA-UHFFFAOYSA-N 649732 rac-3-fluoro-2-hydroxy-5-(2- (4-(pyrrolidin-1- yl)phenyl)morpholine-4- carbonyl)benzaldehyde::US20240043395, Compound 147 Toll-like receptor 2 Homo sapiens 4700 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649732 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649732&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230230 494494576 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372538 Oc1c(F)cc(cc1C=O)C(=O)N1CCOC(C1)c1ccc(cc1)N1CCCC1 InChI=1S/C22H23FN2O4/c23-19-12-16(11-17(14-26)21(19)27)22(28)25-9-10-29-20(13-25)15-3-5-18(6-4-15)24-7-1-2-8-24/h3-6,11-12,14,20,27H,1-2,7-10,13H2 CGOXBCDMYAVXJA-UHFFFAOYSA-N 649732 rac-3-fluoro-2-hydroxy-5-(2- (4-(pyrrolidin-1- yl)phenyl)morpholine-4- carbonyl)benzaldehyde::US20240043395, Compound 147 Toll-like receptor 6 Homo sapiens 1600 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649732 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649732&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230230 494494576 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372539 Oc1c(F)cc(cc1C=O)C(=O)N1CCO[C@H](C1)c1ccc(cc1)N1CCCC1 |r| InChI=1S/C22H23FN2O4/c23-19-12-16(11-17(14-26)21(19)27)22(28)25-9-10-29-20(13-25)15-3-5-18(6-4-15)24-7-1-2-8-24/h3-6,11-12,14,20,27H,1-2,7-10,13H2 CGOXBCDMYAVXJA-UHFFFAOYSA-N 649733 relative-(S)-3-fluoro-2- hydroxy-5-(2-(4-(pyrrolidin-1- yl)phenyl)morpholine-4- carbonyl)benzaldehyde::US20240043395, Compound 148 Toll-like receptor 2 Homo sapiens 4990 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649733 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649733&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230310 494494577 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372540 Oc1c(F)cc(cc1C=O)C(=O)N1CCO[C@H](C1)c1ccc(cc1)N1CCCC1 |r| InChI=1S/C22H23FN2O4/c23-19-12-16(11-17(14-26)21(19)27)22(28)25-9-10-29-20(13-25)15-3-5-18(6-4-15)24-7-1-2-8-24/h3-6,11-12,14,20,27H,1-2,7-10,13H2 CGOXBCDMYAVXJA-UHFFFAOYSA-N 649733 relative-(S)-3-fluoro-2- hydroxy-5-(2-(4-(pyrrolidin-1- yl)phenyl)morpholine-4- carbonyl)benzaldehyde::US20240043395, Compound 148 Toll-like receptor 6 Homo sapiens 1880 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649733 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649733&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230310 494494577 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372541 Oc1c(F)cc(cc1C=O)C(=O)N1CCO[C@@H](C1)c1ccc(cc1)N1CCCC1 |r| InChI=1S/C22H23FN2O4/c23-19-12-16(11-17(14-26)21(19)27)22(28)25-9-10-29-20(13-25)15-3-5-18(6-4-15)24-7-1-2-8-24/h3-6,11-12,14,20,27H,1-2,7-10,13H2 CGOXBCDMYAVXJA-UHFFFAOYSA-N 649734 relative-(R)-3-fluoro-2- hydroxy-5-(2-(4-(pyrrolidin-1- yl)phenyl)morpholine-4- carbonyl)benzaldehyde::US20240043395, Compound 149 Toll-like receptor 2 Homo sapiens 4340 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649734 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649734&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230369 494494578 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372542 Oc1c(F)cc(cc1C=O)C(=O)N1CCO[C@@H](C1)c1ccc(cc1)N1CCCC1 |r| InChI=1S/C22H23FN2O4/c23-19-12-16(11-17(14-26)21(19)27)22(28)25-9-10-29-20(13-25)15-3-5-18(6-4-15)24-7-1-2-8-24/h3-6,11-12,14,20,27H,1-2,7-10,13H2 CGOXBCDMYAVXJA-UHFFFAOYSA-N 649734 relative-(R)-3-fluoro-2- hydroxy-5-(2-(4-(pyrrolidin-1- yl)phenyl)morpholine-4- carbonyl)benzaldehyde::US20240043395, Compound 149 Toll-like receptor 6 Homo sapiens 1740 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649734 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649734&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230369 494494578 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372543 Oc1c(F)cc(cc1C=O)C(=O)N1CCOC(C1)c1cccc(c1)N1CCCC1 InChI=1S/C22H23FN2O4/c23-19-12-16(10-17(14-26)21(19)27)22(28)25-8-9-29-20(13-25)15-4-3-5-18(11-15)24-6-1-2-7-24/h3-5,10-12,14,20,27H,1-2,6-9,13H2 OELKRUUQHVRRJP-UHFFFAOYSA-N 649735 rac-3-fluoro-2-hydroxy-5-(2- (3-(pyrrolidin-1- yl)phenyl)morpholine-4- carbonyl)benzaldehyde::US20240043395, Compound 150 Toll-like receptor 2 Homo sapiens 7500 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649735 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649735&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230267 494494579 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372544 Oc1c(F)cc(cc1C=O)C(=O)N1CCOC(C1)c1cccc(c1)N1CCCC1 InChI=1S/C22H23FN2O4/c23-19-12-16(10-17(14-26)21(19)27)22(28)25-8-9-29-20(13-25)15-4-3-5-18(11-15)24-6-1-2-7-24/h3-5,10-12,14,20,27H,1-2,6-9,13H2 OELKRUUQHVRRJP-UHFFFAOYSA-N 649735 rac-3-fluoro-2-hydroxy-5-(2- (3-(pyrrolidin-1- yl)phenyl)morpholine-4- carbonyl)benzaldehyde::US20240043395, Compound 150 Toll-like receptor 6 Homo sapiens 3100 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649735 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649735&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230267 494494579 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372545 C[C@H]1[C@@H](OCCN1C(=O)c1cc(F)c(O)c(C=O)c1)c1ccc(cc1)N1CCCC1 |r| InChI=1S/C23H25FN2O4/c1-15-22(16-4-6-19(7-5-16)25-8-2-3-9-25)30-11-10-26(15)23(29)17-12-18(14-27)21(28)20(24)13-17/h4-7,12-15,22,28H,2-3,8-11H2,1H3 BIKMRVXUAPINFF-UHFFFAOYSA-N 649736 rac-3-fluoro-2-hydroxy-5- ((2S,3S)-3-methyl-2-(4- (pyrrolidin-1- yl)phenyl)morpholine-4- carbonyl)benzaldehyde::US20240043395, Compound 151 Toll-like receptor 2 Homo sapiens 16900 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649736 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649736&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163229989 494494580 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372546 C[C@H]1[C@@H](OCCN1C(=O)c1cc(F)c(O)c(C=O)c1)c1ccc(cc1)N1CCCC1 |r| InChI=1S/C23H25FN2O4/c1-15-22(16-4-6-19(7-5-16)25-8-2-3-9-25)30-11-10-26(15)23(29)17-12-18(14-27)21(28)20(24)13-17/h4-7,12-15,22,28H,2-3,8-11H2,1H3 BIKMRVXUAPINFF-UHFFFAOYSA-N 649736 rac-3-fluoro-2-hydroxy-5- ((2S,3S)-3-methyl-2-(4- (pyrrolidin-1- yl)phenyl)morpholine-4- carbonyl)benzaldehyde::US20240043395, Compound 151 Toll-like receptor 6 Homo sapiens 7000 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649736 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649736&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163229989 494494580 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372547 COc1ccc(cc1)C1CN(CCS1)C(=O)c1cc(F)c(O)c(C=O)c1 InChI=1S/C19H18FNO4S/c1-25-15-4-2-12(3-5-15)17-10-21(6-7-26-17)19(24)13-8-14(11-22)18(23)16(20)9-13/h2-5,8-9,11,17,23H,6-7,10H2,1H3 OVZRUZCALDFXDD-UHFFFAOYSA-N 649737 rac-3-fluoro-2-hydroxy-5-(2- (4- methoxyphenyl)thiomorpholine- 4-carbonyl)benzaldehyde::US20240043395, Compound 152 Toll-like receptor 2 Homo sapiens 14200 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649737 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649737&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230352 494494581 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372548 COc1ccc(cc1)C1CN(CCS1)C(=O)c1cc(F)c(O)c(C=O)c1 InChI=1S/C19H18FNO4S/c1-25-15-4-2-12(3-5-15)17-10-21(6-7-26-17)19(24)13-8-14(11-22)18(23)16(20)9-13/h2-5,8-9,11,17,23H,6-7,10H2,1H3 OVZRUZCALDFXDD-UHFFFAOYSA-N 649737 rac-3-fluoro-2-hydroxy-5-(2- (4- methoxyphenyl)thiomorpholine- 4-carbonyl)benzaldehyde::US20240043395, Compound 152 Toll-like receptor 6 Homo sapiens 5700 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649737 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649737&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230352 494494581 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372549 Oc1c(F)cc(cc1C=O)C(=O)N1CCS[C@H](C1)c1ccc(cc1)N1CCCC1 |r| InChI=1S/C22H23FN2O3S/c23-19-12-16(11-17(14-26)21(19)27)22(28)25-9-10-29-20(13-25)15-3-5-18(6-4-15)24-7-1-2-8-24/h3-6,11-12,14,20,27H,1-2,7-10,13H2 UVAXMMVEMLCXHM-UHFFFAOYSA-N 649738 relative-(S)-3-fluoro-2- hydroxy-5-(2-(4-(pyrrolidin-1- yl)phenyl)thiomorpholine-4- carbonyl)benzaldehyde::US20240043395, Compound 153 Toll-like receptor 2 Homo sapiens 4800 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649738 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649738&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230082 494494582 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372550 Oc1c(F)cc(cc1C=O)C(=O)N1CCS[C@H](C1)c1ccc(cc1)N1CCCC1 |r| InChI=1S/C22H23FN2O3S/c23-19-12-16(11-17(14-26)21(19)27)22(28)25-9-10-29-20(13-25)15-3-5-18(6-4-15)24-7-1-2-8-24/h3-6,11-12,14,20,27H,1-2,7-10,13H2 UVAXMMVEMLCXHM-UHFFFAOYSA-N 649738 relative-(S)-3-fluoro-2- hydroxy-5-(2-(4-(pyrrolidin-1- yl)phenyl)thiomorpholine-4- carbonyl)benzaldehyde::US20240043395, Compound 153 Toll-like receptor 6 Homo sapiens 1300 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649738 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649738&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230082 494494582 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372551 Oc1c(F)cc(cc1C=O)C(=O)N1CCS[C@@H](C1)c1ccc(cc1)N1CCCC1 |r| InChI=1S/C22H23FN2O3S/c23-19-12-16(11-17(14-26)21(19)27)22(28)25-9-10-29-20(13-25)15-3-5-18(6-4-15)24-7-1-2-8-24/h3-6,11-12,14,20,27H,1-2,7-10,13H2 UVAXMMVEMLCXHM-UHFFFAOYSA-N 649739 relative-(R)-3-fluoro-2- hydroxy-5-(2-(4-(pyrrolidin-1- yl)phenyl)thiomorpholine-4- carbonyl)benzaldehyde::US20240043395, Compound 154 Toll-like receptor 2 Homo sapiens 4300 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649739 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649739&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230061 494494583 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372552 Oc1c(F)cc(cc1C=O)C(=O)N1CCS[C@@H](C1)c1ccc(cc1)N1CCCC1 |r| InChI=1S/C22H23FN2O3S/c23-19-12-16(11-17(14-26)21(19)27)22(28)25-9-10-29-20(13-25)15-3-5-18(6-4-15)24-7-1-2-8-24/h3-6,11-12,14,20,27H,1-2,7-10,13H2 UVAXMMVEMLCXHM-UHFFFAOYSA-N 649739 relative-(R)-3-fluoro-2- hydroxy-5-(2-(4-(pyrrolidin-1- yl)phenyl)thiomorpholine-4- carbonyl)benzaldehyde::US20240043395, Compound 154 Toll-like receptor 6 Homo sapiens 1300 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649739 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649739&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230061 494494583 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372553 Oc1c(F)cc(cc1C=O)C(=O)N1CCCC1c1ccc(cc1)N1CCCC1 InChI=1S/C22H23FN2O3/c23-19-13-16(12-17(14-26)21(19)27)22(28)25-11-3-4-20(25)15-5-7-18(8-6-15)24-9-1-2-10-24/h5-8,12-14,20,27H,1-4,9-11H2 RIXVLRJUHIIZMS-UHFFFAOYSA-N 649740 3-fluoro-2-hydroxy-5-(2-(4- (pyrrolidin-1- yl)phenyl)pyrrolidine-1- carbonyl)benzaldehyde::US20240043395, Compound 155 Toll-like receptor 2 Homo sapiens 15690 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649740 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649740&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163229981 494494584 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372554 Oc1c(F)cc(cc1C=O)C(=O)N1CCCC1c1ccc(cc1)N1CCCC1 InChI=1S/C22H23FN2O3/c23-19-13-16(12-17(14-26)21(19)27)22(28)25-11-3-4-20(25)15-5-7-18(8-6-15)24-9-1-2-10-24/h5-8,12-14,20,27H,1-4,9-11H2 RIXVLRJUHIIZMS-UHFFFAOYSA-N 649740 3-fluoro-2-hydroxy-5-(2-(4- (pyrrolidin-1- yl)phenyl)pyrrolidine-1- carbonyl)benzaldehyde::US20240043395, Compound 155 Toll-like receptor 6 Homo sapiens 9620 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649740 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649740&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163229981 494494584 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372555 Oc1c(F)cc(cc1C=O)C(=O)N1CC[C@@H](C1)c1ccc(cc1)N1CCCC1 |r| InChI=1S/C22H23FN2O3/c23-20-12-17(11-18(14-26)21(20)27)22(28)25-10-7-16(13-25)15-3-5-19(6-4-15)24-8-1-2-9-24/h3-6,11-12,14,16,27H,1-2,7-10,13H2 YMEXYFPTOANDTG-UHFFFAOYSA-N 649741 relative-(R)-3-fluoro-2- hydroxy-5-(3-(4-(pyrrolidin-1- yl)phenyl)pyrrolidine-1- carbonyl)benzaldehyde::US20240043395, Compound 156 Toll-like receptor 2 Homo sapiens 3700 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649741 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649741&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230416 494494585 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372556 Oc1c(F)cc(cc1C=O)C(=O)N1CC[C@@H](C1)c1ccc(cc1)N1CCCC1 |r| InChI=1S/C22H23FN2O3/c23-20-12-17(11-18(14-26)21(20)27)22(28)25-10-7-16(13-25)15-3-5-19(6-4-15)24-8-1-2-9-24/h3-6,11-12,14,16,27H,1-2,7-10,13H2 YMEXYFPTOANDTG-UHFFFAOYSA-N 649741 relative-(R)-3-fluoro-2- hydroxy-5-(3-(4-(pyrrolidin-1- yl)phenyl)pyrrolidine-1- carbonyl)benzaldehyde::US20240043395, Compound 156 Toll-like receptor 6 Homo sapiens 3200 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649741 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649741&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230416 494494585 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372557 Oc1c(F)cc(cc1C=O)C(=O)N1CC[C@H](C1)c1ccc(cc1)N1CCCC1 |r| InChI=1S/C22H23FN2O3/c23-20-12-17(11-18(14-26)21(20)27)22(28)25-10-7-16(13-25)15-3-5-19(6-4-15)24-8-1-2-9-24/h3-6,11-12,14,16,27H,1-2,7-10,13H2 YMEXYFPTOANDTG-UHFFFAOYSA-N 649742 relative-(S)-3-fluoro-2- hydroxy-5-(3-(4-(pyrrolidin-1- yl)phenyl)pyrrolidine-1- carbonyl)benzaldehyde::US20240043395, Compound 157 Toll-like receptor 2 Homo sapiens 3000 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649742 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649742&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230263 494494586 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372558 Oc1c(F)cc(cc1C=O)C(=O)N1CC[C@H](C1)c1ccc(cc1)N1CCCC1 |r| InChI=1S/C22H23FN2O3/c23-20-12-17(11-18(14-26)21(20)27)22(28)25-10-7-16(13-25)15-3-5-19(6-4-15)24-8-1-2-9-24/h3-6,11-12,14,16,27H,1-2,7-10,13H2 YMEXYFPTOANDTG-UHFFFAOYSA-N 649742 relative-(S)-3-fluoro-2- hydroxy-5-(3-(4-(pyrrolidin-1- yl)phenyl)pyrrolidine-1- carbonyl)benzaldehyde::US20240043395, Compound 157 Toll-like receptor 6 Homo sapiens 2200 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649742 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649742&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230263 494494586 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372559 CN(C(=O)c1cc(F)c(O)c(C=O)c1)C12CC(C1)(C2)c1ccccc1 InChI=1S/C20H18FNO3/c1-22(18(25)13-7-14(9-23)17(24)16(21)8-13)20-10-19(11-20,12-20)15-5-3-2-4-6-15/h2-9,24H,10-12H2,1H3 RZTKEVPOEFESID-UHFFFAOYSA-N 649743 3-fluoro-5-formyl-4-hydroxy- N-methyl-N-(3- phenylbicyclo[1.1.1]pentan-1- yl)benzamide::US20240043395, Compound 158 Toll-like receptor 2 Homo sapiens 5900 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649743 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649743&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230068 494494587 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372560 CN(C(=O)c1cc(F)c(O)c(C=O)c1)C12CC(C1)(C2)c1ccccc1 InChI=1S/C20H18FNO3/c1-22(18(25)13-7-14(9-23)17(24)16(21)8-13)20-10-19(11-20,12-20)15-5-3-2-4-6-15/h2-9,24H,10-12H2,1H3 RZTKEVPOEFESID-UHFFFAOYSA-N 649743 3-fluoro-5-formyl-4-hydroxy- N-methyl-N-(3- phenylbicyclo[1.1.1]pentan-1- yl)benzamide::US20240043395, Compound 158 Toll-like receptor 6 Homo sapiens 2250 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649743 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649743&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230068 494494587 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372561 Oc1c(F)cc(COC(=O)Nc2cccc(c2)N2CCCC2)cc1C=O InChI=1S/C19H19FN2O4/c20-17-9-13(8-14(11-23)18(17)24)12-26-19(25)21-15-4-3-5-16(10-15)22-6-1-2-7-22/h3-5,8-11,24H,1-2,6-7,12H2,(H,21,25) WHXKWTYNZWEZQJ-UHFFFAOYSA-N 649744 3-fluoro-5-formyl-4- hydroxybenzyl (3-(pyrrolidin- 1-yl)phenyl)carbamate::US20240043395, Compound 159 Toll-like receptor 2 Homo sapiens 9290 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649744 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649744&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230231 494494588 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372562 Oc1c(F)cc(COC(=O)Nc2cccc(c2)N2CCCC2)cc1C=O InChI=1S/C19H19FN2O4/c20-17-9-13(8-14(11-23)18(17)24)12-26-19(25)21-15-4-3-5-16(10-15)22-6-1-2-7-22/h3-5,8-11,24H,1-2,6-7,12H2,(H,21,25) WHXKWTYNZWEZQJ-UHFFFAOYSA-N 649744 3-fluoro-5-formyl-4- hydroxybenzyl (3-(pyrrolidin- 1-yl)phenyl)carbamate::US20240043395, Compound 159 Toll-like receptor 6 Homo sapiens 4390 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649744 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649744&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230231 494494588 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372563 Oc1c(F)cc(cc1C=O)C(=O)NNc1cccc(Br)c1 InChI=1S/C14H10BrFN2O3/c15-10-2-1-3-11(6-10)17-18-14(21)8-4-9(7-19)13(20)12(16)5-8/h1-7,17,20H,(H,18,21) RGUHJVDDKVEHIW-UHFFFAOYSA-N 649745 N'-(3-bromophenyl)-3-fluoro- 5-formyl-4- hydroxybenzohydrazide::US20240043395, Compound 160 Toll-like receptor 2 Homo sapiens 38390 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649745 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649745&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230052 494494589 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372564 Oc1c(F)cc(cc1C=O)C(=O)NNc1cccc(Br)c1 InChI=1S/C14H10BrFN2O3/c15-10-2-1-3-11(6-10)17-18-14(21)8-4-9(7-19)13(20)12(16)5-8/h1-7,17,20H,(H,18,21) RGUHJVDDKVEHIW-UHFFFAOYSA-N 649745 N'-(3-bromophenyl)-3-fluoro- 5-formyl-4- hydroxybenzohydrazide::US20240043395, Compound 160 Toll-like receptor 6 Homo sapiens 26490 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649745 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649745&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230052 494494589 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372565 Fc1cc(cc(C=O)c1OC(=O)OC1CCOC1)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C24H22FN3O5S/c25-20-12-16(11-17(13-29)21(20)33-24(30)32-19-7-10-31-14-19)23-26-22(27-34-23)15-3-5-18(6-4-15)28-8-1-2-9-28/h3-6,11-13,19H,1-2,7-10,14H2 ZRMNENNPMNNLPA-UHFFFAOYSA-N 649746 2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl)-1,2,4- thiadiazol-5-yl)phenyl (tetrahydrofuran-3-yl) carbonate::US20240043395, Compound 162 Toll-like receptor 2 Homo sapiens 11500 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649746&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163229998 494494590 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372566 Fc1cc(cc(C=O)c1OC(=O)OC1CCOC1)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C24H22FN3O5S/c25-20-12-16(11-17(13-29)21(20)33-24(30)32-19-7-10-31-14-19)23-26-22(27-34-23)15-3-5-18(6-4-15)28-8-1-2-9-28/h3-6,11-13,19H,1-2,7-10,14H2 ZRMNENNPMNNLPA-UHFFFAOYSA-N 649746 2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl)-1,2,4- thiadiazol-5-yl)phenyl (tetrahydrofuran-3-yl) carbonate::US20240043395, Compound 162 Toll-like receptor 6 Homo sapiens 4300 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649746&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163229998 494494590 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372567 CN1CCN(CC1)\N=C\c1cc(cc(F)c1O)C(=O)N1CCC(CC1)c1ccc(cc1)N1CCCC1 InChI=1S/C28H36FN5O2/c1-31-14-16-34(17-15-31)30-20-24-18-23(19-26(29)27(24)35)28(36)33-12-8-22(9-13-33)21-4-6-25(7-5-21)32-10-2-3-11-32/h4-7,18-20,22,35H,2-3,8-17H2,1H3 LEZNYGQGMZHAKH-UHFFFAOYSA-N 649747 (3-fluoro-4-hydroxy-5-(((4- methylpiperazin-1- yl)imino)methyl)phenyl)(4-(4- (pyrrolidin-1- yl)phenyl)piperidin-1- yl)methanone::US20240043395, Compound 163 Toll-like receptor 2 Homo sapiens 600 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649747 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649747&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163229873 494494591 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372568 CN1CCN(CC1)\N=C\c1cc(cc(F)c1O)C(=O)N1CCC(CC1)c1ccc(cc1)N1CCCC1 InChI=1S/C28H36FN5O2/c1-31-14-16-34(17-15-31)30-20-24-18-23(19-26(29)27(24)35)28(36)33-12-8-22(9-13-33)21-4-6-25(7-5-21)32-10-2-3-11-32/h4-7,18-20,22,35H,2-3,8-17H2,1H3 LEZNYGQGMZHAKH-UHFFFAOYSA-N 649747 (3-fluoro-4-hydroxy-5-(((4- methylpiperazin-1- yl)imino)methyl)phenyl)(4-(4- (pyrrolidin-1- yl)phenyl)piperidin-1- yl)methanone::US20240043395, Compound 163 Toll-like receptor 6 Homo sapiens 400 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649747 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649747&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163229873 494494591 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372569 CN1CCN(CC1)\N=C\c1cc(cc(F)c1O)C(=O)N1CCC(CC1)c1ccc(cc1)N1CCCC1 InChI=1S/C28H36FN5O2/c1-31-14-16-34(17-15-31)30-20-24-18-23(19-26(29)27(24)35)28(36)33-12-8-22(9-13-33)21-4-6-25(7-5-21)32-10-2-3-11-32/h4-7,18-20,22,35H,2-3,8-17H2,1H3 LEZNYGQGMZHAKH-UHFFFAOYSA-N 649747 (3-fluoro-4-hydroxy-5-(((4- methylpiperazin-1- yl)imino)methyl)phenyl)(4-(4- (pyrrolidin-1- yl)phenyl)piperidin-1- yl)methanone::US20240043395, Compound 163 Toll-like receptor 9 Homo sapiens 260 US Patent 10.7270/Q2F47T9N aid1963364 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649747 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9962&target=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649747&enzyme=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search 163229873 494494591 1 MGFCRSALHPLSLLVQAIMLAMTLALGTLPAFLPCELQPHGLVNCNWLFLKSVPHFSMAAPRGNVTSLSLSSNRIHHLHDSDFAHLPSLRHLNLKWNCPPVGLSPMHFPCHMTIEPSTFLAVPTLEELNLSYNNIMTVPALPKSLISLSLSHTNILMLDSASLAGLHALRFLFMDGNCYYKNPCRQALEVAPGALLGLGNLTHLSLKYNNLTVVPRNLPSSLEYLLLSYNRIVKLAPEDLANLTALRVLDVGGNCRRCDHAPNPCMECPRHFPQLHPDTFSHLSRLEGLVLKDSSLSWLNASWFRGLGNLRVLDLSENFLYKCITKTKAFQGLTQLRKLNLSFNYQKRVSFAHLSLAPSFGSLVALKELDMHGIFFRSLDETTLRPLARLPMLQTLRLQMNFINQAQLGIFRAFPGLRYVDLSDNRISGASELTATMGEADGGEKVWLQPGDLAPAPVDTPSSEDFRPNCSTLNFTLDLSRNNLVTVQPEMFAQLSHLQCLRLSHNCISQAVNGSQFLPLTGLQVLDLSHNKLDLYHEHSFTELPRLEALDLSYNSQPFGMQGVGHNFSFVAHLRTLRHLSLAHNNIHSQVSQQLCSTSLRALDFSGNALGHMWAEGDLYLHFFQGLSGLIWLDLSQNRLHTLLPQTLRNLPKSLQVLRLRDNYLAFFKWWSLHFLPKLEVLDLAGNQLKALTNGSLPAGTRLRRLDVSCNSISFVAPGFFSKAKELRELNLSANALKTVDHSWFGPLASALQILDVSANPLHCACGAAFMDFLLEVQAAVPGLPSRVKCGSPGQLQGLSIFAQDLRLCLDEALSWDCFALSLLAVALGLGVPMLHHLCGWDLWYCFHLCLAWLPWRGRQSGRDEDALPYDAFVVFDKTQSAVADWVYNELRGQLEECRGRWALRLCLEERDWLPGKTLFENLWASVYGSRKTLFVLAHTDRVSGLLRASFLLAQQRLLEDRKDVVVLVILSPDGRRSRYVRLRQRLCRQSVLLWPHQPSGQRSFWAQLGMALTRDNHHFYNRNFCQGPTAE 8AR3 Toll-like receptor 9 TLR9_HUMAN Q9NR96 B3Y661 D1CS56 Q6UVZ2 Q9HD68 Q9HD69 Q9HD70 Q9NYC2 Q9NYC3 1372570 Oc1c(F)cc(cc1\C=N\N1CCOCC1)C(=O)N1CCC(CC1)c1ccc(cc1)N1CCCC1 InChI=1S/C27H33FN4O3/c28-25-18-22(17-23(26(25)33)19-29-32-13-15-35-16-14-32)27(34)31-11-7-21(8-12-31)20-3-5-24(6-4-20)30-9-1-2-10-30/h3-6,17-19,21,33H,1-2,7-16H2 WMQSENFFMAIIAO-UHFFFAOYSA-N 649748 (3-fluoro-4-hydroxy-5- ((morpholinoimino)methyl) phenyl)(4-(4-(pyrrolidin-1- yl)phenyl)piperidin-1- yl)methanone::US20240043395, Compound 164 Toll-like receptor 2 Homo sapiens 1100 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649748&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230316 494494592 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372571 Oc1c(F)cc(cc1\C=N\N1CCOCC1)C(=O)N1CCC(CC1)c1ccc(cc1)N1CCCC1 InChI=1S/C27H33FN4O3/c28-25-18-22(17-23(26(25)33)19-29-32-13-15-35-16-14-32)27(34)31-11-7-21(8-12-31)20-3-5-24(6-4-20)30-9-1-2-10-30/h3-6,17-19,21,33H,1-2,7-16H2 WMQSENFFMAIIAO-UHFFFAOYSA-N 649748 (3-fluoro-4-hydroxy-5- ((morpholinoimino)methyl) phenyl)(4-(4-(pyrrolidin-1- yl)phenyl)piperidin-1- yl)methanone::US20240043395, Compound 164 Toll-like receptor 6 Homo sapiens 500 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649748&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230316 494494592 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372572 Oc1c(F)cc(cc1\C=N\N1CCOCC1)C(=O)N1CCC(CC1)c1ccc(cc1)N1CCCC1 InChI=1S/C27H33FN4O3/c28-25-18-22(17-23(26(25)33)19-29-32-13-15-35-16-14-32)27(34)31-11-7-21(8-12-31)20-3-5-24(6-4-20)30-9-1-2-10-30/h3-6,17-19,21,33H,1-2,7-16H2 WMQSENFFMAIIAO-UHFFFAOYSA-N 649748 (3-fluoro-4-hydroxy-5- ((morpholinoimino)methyl) phenyl)(4-(4-(pyrrolidin-1- yl)phenyl)piperidin-1- yl)methanone::US20240043395, Compound 164 Toll-like receptor 9 Homo sapiens 260 US Patent 10.7270/Q2F47T9N aid1963364 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9962&target=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649748&enzyme=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search 163230316 494494592 1 MGFCRSALHPLSLLVQAIMLAMTLALGTLPAFLPCELQPHGLVNCNWLFLKSVPHFSMAAPRGNVTSLSLSSNRIHHLHDSDFAHLPSLRHLNLKWNCPPVGLSPMHFPCHMTIEPSTFLAVPTLEELNLSYNNIMTVPALPKSLISLSLSHTNILMLDSASLAGLHALRFLFMDGNCYYKNPCRQALEVAPGALLGLGNLTHLSLKYNNLTVVPRNLPSSLEYLLLSYNRIVKLAPEDLANLTALRVLDVGGNCRRCDHAPNPCMECPRHFPQLHPDTFSHLSRLEGLVLKDSSLSWLNASWFRGLGNLRVLDLSENFLYKCITKTKAFQGLTQLRKLNLSFNYQKRVSFAHLSLAPSFGSLVALKELDMHGIFFRSLDETTLRPLARLPMLQTLRLQMNFINQAQLGIFRAFPGLRYVDLSDNRISGASELTATMGEADGGEKVWLQPGDLAPAPVDTPSSEDFRPNCSTLNFTLDLSRNNLVTVQPEMFAQLSHLQCLRLSHNCISQAVNGSQFLPLTGLQVLDLSHNKLDLYHEHSFTELPRLEALDLSYNSQPFGMQGVGHNFSFVAHLRTLRHLSLAHNNIHSQVSQQLCSTSLRALDFSGNALGHMWAEGDLYLHFFQGLSGLIWLDLSQNRLHTLLPQTLRNLPKSLQVLRLRDNYLAFFKWWSLHFLPKLEVLDLAGNQLKALTNGSLPAGTRLRRLDVSCNSISFVAPGFFSKAKELRELNLSANALKTVDHSWFGPLASALQILDVSANPLHCACGAAFMDFLLEVQAAVPGLPSRVKCGSPGQLQGLSIFAQDLRLCLDEALSWDCFALSLLAVALGLGVPMLHHLCGWDLWYCFHLCLAWLPWRGRQSGRDEDALPYDAFVVFDKTQSAVADWVYNELRGQLEECRGRWALRLCLEERDWLPGKTLFENLWASVYGSRKTLFVLAHTDRVSGLLRASFLLAQQRLLEDRKDVVVLVILSPDGRRSRYVRLRQRLCRQSVLLWPHQPSGQRSFWAQLGMALTRDNHHFYNRNFCQGPTAE 8AR3 Toll-like receptor 9 TLR9_HUMAN Q9NR96 B3Y661 D1CS56 Q6UVZ2 Q9HD68 Q9HD69 Q9HD70 Q9NYC2 Q9NYC3 1372573 CN1CCN(CC1)\N=C\c1cc(cc(F)c1O)-c1nc(ns1)-c1ccc(nc1)N1CCCC1 InChI=1S/C23H26FN7OS/c1-29-8-10-31(11-9-29)26-15-18-12-17(13-19(24)21(18)32)23-27-22(28-33-23)16-4-5-20(25-14-16)30-6-2-3-7-30/h4-5,12-15,32H,2-3,6-11H2,1H3 ZTACONYFETWDLI-UHFFFAOYSA-N 649749 (E)-2-fluoro-6-(((4- methylpiperazin-1- yl)imino)methyl)-4-(3-(6- (pyrrolidin-1-yl)pyridin-3-yl)- 1,2,4-thiadiazol-5-yl)phenol::US20240043395, Compound 165 Toll-like receptor 2 Homo sapiens 1100 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649749 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649749&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230278 494494593 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372574 CN1CCN(CC1)\N=C\c1cc(cc(F)c1O)-c1nc(ns1)-c1ccc(nc1)N1CCCC1 InChI=1S/C23H26FN7OS/c1-29-8-10-31(11-9-29)26-15-18-12-17(13-19(24)21(18)32)23-27-22(28-33-23)16-4-5-20(25-14-16)30-6-2-3-7-30/h4-5,12-15,32H,2-3,6-11H2,1H3 ZTACONYFETWDLI-UHFFFAOYSA-N 649749 (E)-2-fluoro-6-(((4- methylpiperazin-1- yl)imino)methyl)-4-(3-(6- (pyrrolidin-1-yl)pyridin-3-yl)- 1,2,4-thiadiazol-5-yl)phenol::US20240043395, Compound 165 Toll-like receptor 6 Homo sapiens 900 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649749 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649749&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230278 494494593 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372575 CN1CCN(CC1)\N=C\c1cc(cc(F)c1O)-c1nc(ns1)-c1ccc(nc1)N1CCCC1 InChI=1S/C23H26FN7OS/c1-29-8-10-31(11-9-29)26-15-18-12-17(13-19(24)21(18)32)23-27-22(28-33-23)16-4-5-20(25-14-16)30-6-2-3-7-30/h4-5,12-15,32H,2-3,6-11H2,1H3 ZTACONYFETWDLI-UHFFFAOYSA-N 649749 (E)-2-fluoro-6-(((4- methylpiperazin-1- yl)imino)methyl)-4-(3-(6- (pyrrolidin-1-yl)pyridin-3-yl)- 1,2,4-thiadiazol-5-yl)phenol::US20240043395, Compound 165 Toll-like receptor 9 Homo sapiens 410 US Patent 10.7270/Q2F47T9N aid1963364 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649749 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9962&target=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649749&enzyme=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search 163230278 494494593 1 MGFCRSALHPLSLLVQAIMLAMTLALGTLPAFLPCELQPHGLVNCNWLFLKSVPHFSMAAPRGNVTSLSLSSNRIHHLHDSDFAHLPSLRHLNLKWNCPPVGLSPMHFPCHMTIEPSTFLAVPTLEELNLSYNNIMTVPALPKSLISLSLSHTNILMLDSASLAGLHALRFLFMDGNCYYKNPCRQALEVAPGALLGLGNLTHLSLKYNNLTVVPRNLPSSLEYLLLSYNRIVKLAPEDLANLTALRVLDVGGNCRRCDHAPNPCMECPRHFPQLHPDTFSHLSRLEGLVLKDSSLSWLNASWFRGLGNLRVLDLSENFLYKCITKTKAFQGLTQLRKLNLSFNYQKRVSFAHLSLAPSFGSLVALKELDMHGIFFRSLDETTLRPLARLPMLQTLRLQMNFINQAQLGIFRAFPGLRYVDLSDNRISGASELTATMGEADGGEKVWLQPGDLAPAPVDTPSSEDFRPNCSTLNFTLDLSRNNLVTVQPEMFAQLSHLQCLRLSHNCISQAVNGSQFLPLTGLQVLDLSHNKLDLYHEHSFTELPRLEALDLSYNSQPFGMQGVGHNFSFVAHLRTLRHLSLAHNNIHSQVSQQLCSTSLRALDFSGNALGHMWAEGDLYLHFFQGLSGLIWLDLSQNRLHTLLPQTLRNLPKSLQVLRLRDNYLAFFKWWSLHFLPKLEVLDLAGNQLKALTNGSLPAGTRLRRLDVSCNSISFVAPGFFSKAKELRELNLSANALKTVDHSWFGPLASALQILDVSANPLHCACGAAFMDFLLEVQAAVPGLPSRVKCGSPGQLQGLSIFAQDLRLCLDEALSWDCFALSLLAVALGLGVPMLHHLCGWDLWYCFHLCLAWLPWRGRQSGRDEDALPYDAFVVFDKTQSAVADWVYNELRGQLEECRGRWALRLCLEERDWLPGKTLFENLWASVYGSRKTLFVLAHTDRVSGLLRASFLLAQQRLLEDRKDVVVLVILSPDGRRSRYVRLRQRLCRQSVLLWPHQPSGQRSFWAQLGMALTRDNHHFYNRNFCQGPTAE 8AR3 Toll-like receptor 9 TLR9_HUMAN Q9NR96 B3Y661 D1CS56 Q6UVZ2 Q9HD68 Q9HD69 Q9HD70 Q9NYC2 Q9NYC3 1372576 Oc1c(F)cc(cc1\C=N\N1CCOCC1)-c1nc(ns1)-c1ccc(nc1)N1CCCC1 InChI=1S/C22H23FN6O2S/c23-18-12-16(11-17(20(18)30)14-25-29-7-9-31-10-8-29)22-26-21(27-32-22)15-3-4-19(24-13-15)28-5-1-2-6-28/h3-4,11-14,30H,1-2,5-10H2 HJOSEWUCFHLGBE-UHFFFAOYSA-N 649750 2-fluoro-6- ((morpholinoimino)methyl)-4- (3-(4-(pyrrolidin-1-yl)phenyl)- 1,2,4-thiadiazol-5-yl)phenol::US20240043395, Compound 166 Toll-like receptor 2 Homo sapiens 2800 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649750&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 170687924 494494594 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372577 Oc1c(F)cc(cc1\C=N\N1CCOCC1)-c1nc(ns1)-c1ccc(nc1)N1CCCC1 InChI=1S/C22H23FN6O2S/c23-18-12-16(11-17(20(18)30)14-25-29-7-9-31-10-8-29)22-26-21(27-32-22)15-3-4-19(24-13-15)28-5-1-2-6-28/h3-4,11-14,30H,1-2,5-10H2 HJOSEWUCFHLGBE-UHFFFAOYSA-N 649750 2-fluoro-6- ((morpholinoimino)methyl)-4- (3-(4-(pyrrolidin-1-yl)phenyl)- 1,2,4-thiadiazol-5-yl)phenol::US20240043395, Compound 166 Toll-like receptor 6 Homo sapiens 1000 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649750&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 170687924 494494594 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372578 Oc1c(F)cc(cc1\C=N\N1CCOCC1)-c1nc(ns1)-c1ccc(nc1)N1CCCC1 InChI=1S/C22H23FN6O2S/c23-18-12-16(11-17(20(18)30)14-25-29-7-9-31-10-8-29)22-26-21(27-32-22)15-3-4-19(24-13-15)28-5-1-2-6-28/h3-4,11-14,30H,1-2,5-10H2 HJOSEWUCFHLGBE-UHFFFAOYSA-N 649750 2-fluoro-6- ((morpholinoimino)methyl)-4- (3-(4-(pyrrolidin-1-yl)phenyl)- 1,2,4-thiadiazol-5-yl)phenol::US20240043395, Compound 166 Toll-like receptor 9 Homo sapiens 140 US Patent 10.7270/Q2F47T9N aid1963364 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9962&target=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649750&enzyme=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search 170687924 494494594 1 MGFCRSALHPLSLLVQAIMLAMTLALGTLPAFLPCELQPHGLVNCNWLFLKSVPHFSMAAPRGNVTSLSLSSNRIHHLHDSDFAHLPSLRHLNLKWNCPPVGLSPMHFPCHMTIEPSTFLAVPTLEELNLSYNNIMTVPALPKSLISLSLSHTNILMLDSASLAGLHALRFLFMDGNCYYKNPCRQALEVAPGALLGLGNLTHLSLKYNNLTVVPRNLPSSLEYLLLSYNRIVKLAPEDLANLTALRVLDVGGNCRRCDHAPNPCMECPRHFPQLHPDTFSHLSRLEGLVLKDSSLSWLNASWFRGLGNLRVLDLSENFLYKCITKTKAFQGLTQLRKLNLSFNYQKRVSFAHLSLAPSFGSLVALKELDMHGIFFRSLDETTLRPLARLPMLQTLRLQMNFINQAQLGIFRAFPGLRYVDLSDNRISGASELTATMGEADGGEKVWLQPGDLAPAPVDTPSSEDFRPNCSTLNFTLDLSRNNLVTVQPEMFAQLSHLQCLRLSHNCISQAVNGSQFLPLTGLQVLDLSHNKLDLYHEHSFTELPRLEALDLSYNSQPFGMQGVGHNFSFVAHLRTLRHLSLAHNNIHSQVSQQLCSTSLRALDFSGNALGHMWAEGDLYLHFFQGLSGLIWLDLSQNRLHTLLPQTLRNLPKSLQVLRLRDNYLAFFKWWSLHFLPKLEVLDLAGNQLKALTNGSLPAGTRLRRLDVSCNSISFVAPGFFSKAKELRELNLSANALKTVDHSWFGPLASALQILDVSANPLHCACGAAFMDFLLEVQAAVPGLPSRVKCGSPGQLQGLSIFAQDLRLCLDEALSWDCFALSLLAVALGLGVPMLHHLCGWDLWYCFHLCLAWLPWRGRQSGRDEDALPYDAFVVFDKTQSAVADWVYNELRGQLEECRGRWALRLCLEERDWLPGKTLFENLWASVYGSRKTLFVLAHTDRVSGLLRASFLLAQQRLLEDRKDVVVLVILSPDGRRSRYVRLRQRLCRQSVLLWPHQPSGQRSFWAQLGMALTRDNHHFYNRNFCQGPTAE 8AR3 Toll-like receptor 9 TLR9_HUMAN Q9NR96 B3Y661 D1CS56 Q6UVZ2 Q9HD68 Q9HD69 Q9HD70 Q9NYC2 Q9NYC3 1372579 Oc1c(F)cc(cc1C=O)C(=O)Nc1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C20H17FN4O3S/c21-16-10-13(9-14(11-26)17(16)27)19(28)23-20-22-18(24-29-20)12-3-5-15(6-4-12)25-7-1-2-8-25/h3-6,9-11,27H,1-2,7-8H2,(H,22,23,24,28) RTOSOVQNEONXAC-UHFFFAOYSA-N 649751 3-fluoro-5-formyl-4-hydroxy- N-(3-(4-(pyrrolidin-1- yl)phenyl)-1,2,4-thiadiazol-5- yl)benzamide::US20240043395, Compound 167 Toll-like receptor 2 Homo sapiens 1500 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649751 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649751&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230424 494494595 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372580 Oc1c(F)cc(cc1C=O)C(=O)Nc1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C20H17FN4O3S/c21-16-10-13(9-14(11-26)17(16)27)19(28)23-20-22-18(24-29-20)12-3-5-15(6-4-12)25-7-1-2-8-25/h3-6,9-11,27H,1-2,7-8H2,(H,22,23,24,28) RTOSOVQNEONXAC-UHFFFAOYSA-N 649751 3-fluoro-5-formyl-4-hydroxy- N-(3-(4-(pyrrolidin-1- yl)phenyl)-1,2,4-thiadiazol-5- yl)benzamide::US20240043395, Compound 167 Toll-like receptor 6 Homo sapiens 600 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649751 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649751&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230424 494494595 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372581 Oc1c(F)cc(cc1C=O)C(=O)Nc1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C20H17FN4O3S/c21-16-10-13(9-14(11-26)17(16)27)19(28)23-20-22-18(24-29-20)12-3-5-15(6-4-12)25-7-1-2-8-25/h3-6,9-11,27H,1-2,7-8H2,(H,22,23,24,28) RTOSOVQNEONXAC-UHFFFAOYSA-N 649751 3-fluoro-5-formyl-4-hydroxy- N-(3-(4-(pyrrolidin-1- yl)phenyl)-1,2,4-thiadiazol-5- yl)benzamide::US20240043395, Compound 167 Toll-like receptor 9 Homo sapiens 500 US Patent 10.7270/Q2F47T9N aid1963364 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649751 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9962&target=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649751&enzyme=Toll-like+receptor+9&column=ki&startPg=0&Increment=50&submit=Search 163230424 494494595 1 MGFCRSALHPLSLLVQAIMLAMTLALGTLPAFLPCELQPHGLVNCNWLFLKSVPHFSMAAPRGNVTSLSLSSNRIHHLHDSDFAHLPSLRHLNLKWNCPPVGLSPMHFPCHMTIEPSTFLAVPTLEELNLSYNNIMTVPALPKSLISLSLSHTNILMLDSASLAGLHALRFLFMDGNCYYKNPCRQALEVAPGALLGLGNLTHLSLKYNNLTVVPRNLPSSLEYLLLSYNRIVKLAPEDLANLTALRVLDVGGNCRRCDHAPNPCMECPRHFPQLHPDTFSHLSRLEGLVLKDSSLSWLNASWFRGLGNLRVLDLSENFLYKCITKTKAFQGLTQLRKLNLSFNYQKRVSFAHLSLAPSFGSLVALKELDMHGIFFRSLDETTLRPLARLPMLQTLRLQMNFINQAQLGIFRAFPGLRYVDLSDNRISGASELTATMGEADGGEKVWLQPGDLAPAPVDTPSSEDFRPNCSTLNFTLDLSRNNLVTVQPEMFAQLSHLQCLRLSHNCISQAVNGSQFLPLTGLQVLDLSHNKLDLYHEHSFTELPRLEALDLSYNSQPFGMQGVGHNFSFVAHLRTLRHLSLAHNNIHSQVSQQLCSTSLRALDFSGNALGHMWAEGDLYLHFFQGLSGLIWLDLSQNRLHTLLPQTLRNLPKSLQVLRLRDNYLAFFKWWSLHFLPKLEVLDLAGNQLKALTNGSLPAGTRLRRLDVSCNSISFVAPGFFSKAKELRELNLSANALKTVDHSWFGPLASALQILDVSANPLHCACGAAFMDFLLEVQAAVPGLPSRVKCGSPGQLQGLSIFAQDLRLCLDEALSWDCFALSLLAVALGLGVPMLHHLCGWDLWYCFHLCLAWLPWRGRQSGRDEDALPYDAFVVFDKTQSAVADWVYNELRGQLEECRGRWALRLCLEERDWLPGKTLFENLWASVYGSRKTLFVLAHTDRVSGLLRASFLLAQQRLLEDRKDVVVLVILSPDGRRSRYVRLRQRLCRQSVLLWPHQPSGQRSFWAQLGMALTRDNHHFYNRNFCQGPTAE 8AR3 Toll-like receptor 9 TLR9_HUMAN Q9NR96 B3Y661 D1CS56 Q6UVZ2 Q9HD68 Q9HD69 Q9HD70 Q9NYC2 Q9NYC3 1372582 Oc1c(F)cc(cc1C=O)C(=O)Nc1cnc(s1)-c1ccnc(c1)N1CCCC1 InChI=1S/C20H17FN4O3S/c21-15-8-13(7-14(11-26)18(15)27)19(28)24-17-10-23-20(29-17)12-3-4-22-16(9-12)25-5-1-2-6-25/h3-4,7-11,27H,1-2,5-6H2,(H,24,28) CMQWKFWMNQTTFQ-UHFFFAOYSA-N 649752 3-fluoro-5-formyl-4-hydroxy- N-(2-(2-(pyrrolidin-1- yl)pyridin-4-yl)thiazol-5- yl)benzamide::US20240043395, Compound 168 Toll-like receptor 2 Homo sapiens 15800 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649752 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649752&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230031 494494596 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372583 Oc1c(F)cc(cc1C=O)C(=O)Nc1cnc(s1)-c1ccnc(c1)N1CCCC1 InChI=1S/C20H17FN4O3S/c21-15-8-13(7-14(11-26)18(15)27)19(28)24-17-10-23-20(29-17)12-3-4-22-16(9-12)25-5-1-2-6-25/h3-4,7-11,27H,1-2,5-6H2,(H,24,28) CMQWKFWMNQTTFQ-UHFFFAOYSA-N 649752 3-fluoro-5-formyl-4-hydroxy- N-(2-(2-(pyrrolidin-1- yl)pyridin-4-yl)thiazol-5- yl)benzamide::US20240043395, Compound 168 Toll-like receptor 6 Homo sapiens 9600 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649752 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649752&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230031 494494596 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372584 Oc1c(F)cc(cc1C=O)-c1nc(ns1)-c1ccc(cc1)N1CC(F)(F)C1 InChI=1S/C18H12F3N3O2S/c19-14-6-11(5-12(7-25)15(14)26)17-22-16(23-27-17)10-1-3-13(4-2-10)24-8-18(20,21)9-24/h1-7,26H,8-9H2 QFYXKDYKPXQMIM-UHFFFAOYSA-N 649753 5-(3-(4-(3,3-difluoroazetidin- 1-yl)phenyl)-1,2,4-thiadiazol- 5-yl)-3-fluoro-2- hydroxybenzaldehyde::US20240043395, Compound 169 Toll-like receptor 2 Homo sapiens 2500 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649753&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230025 494494597 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372585 Oc1c(F)cc(cc1C=O)-c1nc(ns1)-c1ccc(cc1)N1CC(F)(F)C1 InChI=1S/C18H12F3N3O2S/c19-14-6-11(5-12(7-25)15(14)26)17-22-16(23-27-17)10-1-3-13(4-2-10)24-8-18(20,21)9-24/h1-7,26H,8-9H2 QFYXKDYKPXQMIM-UHFFFAOYSA-N 649753 5-(3-(4-(3,3-difluoroazetidin- 1-yl)phenyl)-1,2,4-thiadiazol- 5-yl)-3-fluoro-2- hydroxybenzaldehyde::US20240043395, Compound 169 Toll-like receptor 6 Homo sapiens 1300 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649753&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230025 494494597 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372586 NS(=O)(=O)c1ccc(cc1)-c1nsc(n1)-c1cc(F)c(O)c(C=O)c1 InChI=1S/C15H10FN3O4S2/c16-12-6-9(5-10(7-20)13(12)21)15-18-14(19-24-15)8-1-3-11(4-2-8)25(17,22)23/h1-7,21H,(H2,17,22,23) ULLGBYMQWCEKHX-UHFFFAOYSA-N 649754 4-(5-(3-fluoro-5-formyl-4- hydroxyphenyl)-1,2,4- thiadiazol-3- yl)benzenesulfonamide::US20240043395, Compound 170 Toll-like receptor 2 Homo sapiens 17710 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649754 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649754&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230211 494494598 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372587 NS(=O)(=O)c1ccc(cc1)-c1nsc(n1)-c1cc(F)c(O)c(C=O)c1 InChI=1S/C15H10FN3O4S2/c16-12-6-9(5-10(7-20)13(12)21)15-18-14(19-24-15)8-1-3-11(4-2-8)25(17,22)23/h1-7,21H,(H2,17,22,23) ULLGBYMQWCEKHX-UHFFFAOYSA-N 649754 4-(5-(3-fluoro-5-formyl-4- hydroxyphenyl)-1,2,4- thiadiazol-3- yl)benzenesulfonamide::US20240043395, Compound 170 Toll-like receptor 6 Homo sapiens 5360 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649754 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649754&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230211 494494598 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372588 O\N=C/c1cc(cc(F)c1O)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C19H17FN4O2S/c20-16-10-13(9-14(11-21-26)17(16)25)19-22-18(23-27-19)12-3-5-15(6-4-12)24-7-1-2-8-24/h3-6,9-11,25-26H,1-2,7-8H2 MSZGUZPPDKPRNH-UHFFFAOYSA-N 649755 (Z)-3-fluoro-2-hydroxy-5-(3- (4-(pyrrolidin-1-yl)phenyl)- 1,2,4-thiadiazol-5- yl)benzaldehyde oxime::US20240043395, Compound 171 Toll-like receptor 2 Homo sapiens 2520 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649755&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230413 494494599 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372589 O\N=C/c1cc(cc(F)c1O)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C19H17FN4O2S/c20-16-10-13(9-14(11-21-26)17(16)25)19-22-18(23-27-19)12-3-5-15(6-4-12)24-7-1-2-8-24/h3-6,9-11,25-26H,1-2,7-8H2 MSZGUZPPDKPRNH-UHFFFAOYSA-N 649755 (Z)-3-fluoro-2-hydroxy-5-(3- (4-(pyrrolidin-1-yl)phenyl)- 1,2,4-thiadiazol-5- yl)benzaldehyde oxime::US20240043395, Compound 171 Toll-like receptor 6 Homo sapiens 1030 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649755&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230413 494494599 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372590 Fc1cc(cc(C=O)c1OC(=O)N1CCCC1)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C24H23FN4O3S/c25-20-14-17(13-18(15-30)21(20)32-24(31)29-11-3-4-12-29)23-26-22(27-33-23)16-5-7-19(8-6-16)28-9-1-2-10-28/h5-8,13-15H,1-4,9-12H2 IBUNWGCPQRDSJW-UHFFFAOYSA-N 649756 2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl)-1,2,4- thiadiazol-5-yl)phenyl pyrrolidine-1-carboxylate::US20240043395, Compound 172 Toll-like receptor 2 Homo sapiens 1000 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649756 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649756&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230287 494494600 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372591 Fc1cc(cc(C=O)c1OC(=O)N1CCCC1)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C24H23FN4O3S/c25-20-14-17(13-18(15-30)21(20)32-24(31)29-11-3-4-12-29)23-26-22(27-33-23)16-5-7-19(8-6-16)28-9-1-2-10-28/h5-8,13-15H,1-4,9-12H2 IBUNWGCPQRDSJW-UHFFFAOYSA-N 649756 2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl)-1,2,4- thiadiazol-5-yl)phenyl pyrrolidine-1-carboxylate::US20240043395, Compound 172 Toll-like receptor 6 Homo sapiens 500 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649756 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649756&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230287 494494600 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372592 CN(C)C(=O)Oc1c(F)cc(cc1C=O)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C22H21FN4O3S/c1-26(2)22(29)30-19-16(13-28)11-15(12-18(19)23)21-24-20(25-31-21)14-5-7-17(8-6-14)27-9-3-4-10-27/h5-8,11-13H,3-4,9-10H2,1-2H3 LLLQWYGRBDZJLI-UHFFFAOYSA-N 649757 2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl)-1,2,4- thiadiazol-5-yl)phenyl dimethylcarbamate::US20240043395, Compound 173 Toll-like receptor 2 Homo sapiens 900 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649757&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230272 494494601 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372593 CN(C)C(=O)Oc1c(F)cc(cc1C=O)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C22H21FN4O3S/c1-26(2)22(29)30-19-16(13-28)11-15(12-18(19)23)21-24-20(25-31-21)14-5-7-17(8-6-14)27-9-3-4-10-27/h5-8,11-13H,3-4,9-10H2,1-2H3 LLLQWYGRBDZJLI-UHFFFAOYSA-N 649757 2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl)-1,2,4- thiadiazol-5-yl)phenyl dimethylcarbamate::US20240043395, Compound 173 Toll-like receptor 6 Homo sapiens 500 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649757&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230272 494494601 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372594 Fc1cc(cc(C=O)c1OC(=O)N1CCOCC1)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C24H23FN4O4S/c25-20-14-17(13-18(15-30)21(20)33-24(31)29-9-11-32-12-10-29)23-26-22(27-34-23)16-3-5-19(6-4-16)28-7-1-2-8-28/h3-6,13-15H,1-2,7-12H2 HGLIOMQJPFQANC-UHFFFAOYSA-N 649758 2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl)-1,2,4- thiadiazol-5-yl)phenyl morpholine-4-carboxylate::US20240043395, Compound 174 Toll-like receptor 2 Homo sapiens 1500 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649758 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649758&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230086 494494602 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372595 Fc1cc(cc(C=O)c1OC(=O)N1CCOCC1)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C24H23FN4O4S/c25-20-14-17(13-18(15-30)21(20)33-24(31)29-9-11-32-12-10-29)23-26-22(27-34-23)16-3-5-19(6-4-16)28-7-1-2-8-28/h3-6,13-15H,1-2,7-12H2 HGLIOMQJPFQANC-UHFFFAOYSA-N 649758 2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl)-1,2,4- thiadiazol-5-yl)phenyl morpholine-4-carboxylate::US20240043395, Compound 174 Toll-like receptor 6 Homo sapiens 600 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649758 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649758&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230086 494494602 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372596 CN1CCN(CC1)C(=O)Oc1c(F)cc(cc1C=O)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C25H26FN5O3S/c1-29-10-12-31(13-11-29)25(33)34-22-19(16-32)14-18(15-21(22)26)24-27-23(28-35-24)17-4-6-20(7-5-17)30-8-2-3-9-30/h4-7,14-16H,2-3,8-13H2,1H3 IOYGOGYUPUVKSF-UHFFFAOYSA-N 649759 2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl)-1,2,4- thiadiazol-5-yl)phenyl 4- methylpiperazine-1- carboxylate::US20240043395, Compound 175 Toll-like receptor 2 Homo sapiens 1200 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649759&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230290 494494603 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372597 CN1CCN(CC1)C(=O)Oc1c(F)cc(cc1C=O)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C25H26FN5O3S/c1-29-10-12-31(13-11-29)25(33)34-22-19(16-32)14-18(15-21(22)26)24-27-23(28-35-24)17-4-6-20(7-5-17)30-8-2-3-9-30/h4-7,14-16H,2-3,8-13H2,1H3 IOYGOGYUPUVKSF-UHFFFAOYSA-N 649759 2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl)-1,2,4- thiadiazol-5-yl)phenyl 4- methylpiperazine-1- carboxylate::US20240043395, Compound 175 Toll-like receptor 6 Homo sapiens 300 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649759&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230290 494494603 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372598 COCCOCC(=O)Oc1c(F)cc(cc1C=O)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C24H24FN3O5S/c1-31-10-11-32-15-21(30)33-22-18(14-29)12-17(13-20(22)25)24-26-23(27-34-24)16-4-6-19(7-5-16)28-8-2-3-9-28/h4-7,12-14H,2-3,8-11,15H2,1H3 LABMZIVLMHSMDS-UHFFFAOYSA-N 649760 2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl)-1,2,4- thiadiazol-5-yl)phenyl 2-(2- methoxyethoxy)acetate::US20240043395, Compound 176 Toll-like receptor 2 Homo sapiens 2000 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649760 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649760&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163229999 494494604 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372599 COCCOCC(=O)Oc1c(F)cc(cc1C=O)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C24H24FN3O5S/c1-31-10-11-32-15-21(30)33-22-18(14-29)12-17(13-20(22)25)24-26-23(27-34-24)16-4-6-19(7-5-16)28-8-2-3-9-28/h4-7,12-14H,2-3,8-11,15H2,1H3 LABMZIVLMHSMDS-UHFFFAOYSA-N 649760 2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl)-1,2,4- thiadiazol-5-yl)phenyl 2-(2- methoxyethoxy)acetate::US20240043395, Compound 176 Toll-like receptor 6 Homo sapiens 600 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649760 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649760&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163229999 494494604 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372600 C[n+]1ccccc1Oc1c(F)cc(cc1C=O)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C25H22FN4O2S/c1-29-11-3-2-6-22(29)32-23-19(16-31)14-18(15-21(23)26)25-27-24(28-33-25)17-7-9-20(10-8-17)30-12-4-5-13-30/h2-3,6-11,14-16H,4-5,12-13H2,1H3/q+1 XYMXJDVIYUUJKK-UHFFFAOYSA-N 649761 2-(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl)-1,2,4- thiadiazol-5-yl)phenoxy)-1- methylpyridin-1-ium::US20240043395, Compound 177 Toll-like receptor 2 Homo sapiens 1600 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649761&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230149 494494605 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372601 C[n+]1ccccc1Oc1c(F)cc(cc1C=O)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C25H22FN4O2S/c1-29-11-3-2-6-22(29)32-23-19(16-31)14-18(15-21(23)26)25-27-24(28-33-25)17-7-9-20(10-8-17)30-12-4-5-13-30/h2-3,6-11,14-16H,4-5,12-13H2,1H3/q+1 XYMXJDVIYUUJKK-UHFFFAOYSA-N 649761 2-(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl)-1,2,4- thiadiazol-5-yl)phenoxy)-1- methylpyridin-1-ium::US20240043395, Compound 177 Toll-like receptor 6 Homo sapiens 600 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649761&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230149 494494605 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372602 CN1C(O)c2cc(cc(F)c2OC1=O)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C21H19FN4O3S/c1-25-20(27)15-10-13(11-16(22)17(15)29-21(25)28)19-23-18(24-30-19)12-4-6-14(7-5-12)26-8-2-3-9-26/h4-7,10-11,20,27H,2-3,8-9H2,1H3 LSKZVQUIYSBHHS-UHFFFAOYSA-N 649762 8-fluoro-4-hydroxy-3-methyl- 6-(3-(4-(pyrrolidin-1- yl)phenyl)-1,2,4-thiadiazol-5- yl)-3,4-dihydro-2H- benzo[e][1,3]oxazin-2-one::US20240043395, Compound 178 Toll-like receptor 2 Homo sapiens 1200 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649762 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649762&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230408 494494606 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372603 CN1C(O)c2cc(cc(F)c2OC1=O)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C21H19FN4O3S/c1-25-20(27)15-10-13(11-16(22)17(15)29-21(25)28)19-23-18(24-30-19)12-4-6-14(7-5-12)26-8-2-3-9-26/h4-7,10-11,20,27H,2-3,8-9H2,1H3 LSKZVQUIYSBHHS-UHFFFAOYSA-N 649762 8-fluoro-4-hydroxy-3-methyl- 6-(3-(4-(pyrrolidin-1- yl)phenyl)-1,2,4-thiadiazol-5- yl)-3,4-dihydro-2H- benzo[e][1,3]oxazin-2-one::US20240043395, Compound 178 Toll-like receptor 6 Homo sapiens 430 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649762 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649762&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230408 494494606 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3 1372604 COCCN1C(O)c2cc(cc(F)c2OC1=O)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C23H23FN4O4S/c1-31-11-10-28-22(29)17-12-15(13-18(24)19(17)32-23(28)30)21-25-20(26-33-21)14-4-6-16(7-5-14)27-8-2-3-9-27/h4-7,12-13,22,29H,2-3,8-11H2,1H3 FTGAKYZOANSYNW-UHFFFAOYSA-N 649763 8-fluoro-4-hydroxy-3-(2- methoxyethyl)-6-(3-(4- (pyrrolidin-1-yl)phenyl)-1,2,4- thiadiazol-5-yl)-3,4-dihydro- 2H-benzo[e][1,3]oxazin-2-one::US20240043395, Compound 179 Toll-like receptor 2 Homo sapiens 800 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649763 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649763&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 163230429 494494607 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 1372605 COCCN1C(O)c2cc(cc(F)c2OC1=O)-c1nc(ns1)-c1ccc(cc1)N1CCCC1 InChI=1S/C23H23FN4O4S/c1-31-11-10-28-22(29)17-12-15(13-18(24)19(17)32-23(28)30)21-25-20(26-33-21)14-4-6-16(7-5-14)27-8-2-3-9-27/h4-7,12-13,22,29H,2-3,8-11H2,1H3 FTGAKYZOANSYNW-UHFFFAOYSA-N 649763 8-fluoro-4-hydroxy-3-(2- methoxyethyl)-6-(3-(4- (pyrrolidin-1-yl)phenyl)-1,2,4- thiadiazol-5-yl)-3,4-dihydro- 2H-benzo[e][1,3]oxazin-2-one::US20240043395, Compound 179 Toll-like receptor 6 Homo sapiens 200 US Patent 10.7270/Q2F47T9N aid1963363 US20240043395 NATALA, SR; WRASIDLO, WJ; STOCKING, EM 2/8/2024 4/12/2024 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=649763 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50001165&target=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=649763&enzyme=Toll-like+receptor+6&column=ki&startPg=0&Increment=50&submit=Search 163230429 494494607 1 MTKDKEPIVKSFHFVCLMIIIVGTRIQFSDGNEFAVDKSKRGLIHVPKDLPLKTKVLDMSQNYIAELQVSDMSFLSELTVLRLSHNRIQLLDLSVFKFNQDLEYLDLSHNQLQKISCHPIVSFRHLDLSFNDFKALPICKEFGNLSQLNFLGLSAMKLQKLDLLPIAHLHLSYILLDLRNYYIKENETESLQILNAKTLHLVFHPTSLFAIQVNISVNTLGCLQLTNIKLNDDNCQVFIKFLSELTRGSTLLNFTLNHIETTWKCLVRVFQFLWPKPVEYLNIYNLTIIESIREEDFTYSKTTLKALTIEHITNQVFLFSQTALYTVFSEMNIMMLTISDTPFIHMLCPHAPSTFKFLNFTQNVFTDSIFEKCSTLVKLETLILQKNGLKDLFKVGLMTKDMPSLEILDVSWNSLESGRHKENCTWVESIVVLNLSSNMLTDSVFRCLPPRIKVLDLHSNKIKSVPKQVVKLEALQELNVAFNSLTDLPGCGSFSSLSVLIIDHNSVSHPSADFFQSCQKMRSIKAGDNPFQCTCELREFVKNIDQVSSEVLEGWPDSYKCDYPESYRGSPLKDFHMSELSCNITLLIVTIGATMLVLAVTVTSLCIYLDLPWYLRMVCQWTQTRRRARNIPLEELQRNLQFHAFISYSEHDSAWVKSELVPYLEKEDIQICLHERNFVPGKSIVENIINCIEKSYKSIFVLSPNFVQSEWCHYELYFAHHNLFHEGSNNLILILLEPIPQNSIPNKYHKLKALMTQRTYLQWPKEKSKRGLFWANIRAAFNMKLTLVTENNDVKS 4OM7 Toll-like receptor 6 TLR6_HUMAN Q9Y2C9 B3Y640 B6CH35 B6RFS4 B6RFS5 Q2NKL3